{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 218564, "items": [{"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T14:13:48Z", "timestamp": 1574172828113}, "reference-count": 66, "publisher": "Elsevier BV", "issue": "18", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2003, 9, 1]], "date-time": "2003-09-01T00:00:00Z", "timestamp": 1062374400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drug Discovery Today"], "published-print": {"date-parts": [[2003, 9]]}, "DOI": "10.1016/s1359-6446(03)02828-9", "type": "journal-article", "created": {"date-parts": [[2003, 9, 12]], "date-time": "2003-09-12T14:49:36Z", "timestamp": 1063378176000}, "page": "852-861", "source": "Crossref", "is-referenced-by-count": 77, "title": ["ADME\u2013Tox in drug discovery: integration of experimental and computational technologies"], "prefix": "10.1016", "volume": "8", "author": [{"given": "Hongshi", "family": "Yu", "sequence": "first", "affiliation": []}, {"given": "Adedayo", "family": "Adedoyin", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Drug Discovery Today"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1359644603028289?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1359644603028289?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 24]], "date-time": "2019-02-24T13:20:56Z", "timestamp": 1551014456000}, "score": 62.96366, "issued": {"date-parts": [[2003, 9]]}, "references-count": 66, "journal-issue": {"published-print": {"date-parts": [[2003, 9]]}, "issue": "18"}, "alternative-id": ["S1359644603028289"], "URL": "http://dx.doi.org/10.1016/s1359-6446(03)02828-9", "ISSN": ["1359-6446"], "issn-type": [{"value": "1359-6446", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T16:29:46Z", "timestamp": 1575476986037}, "reference-count": 66, "publisher": "Elsevier BV", "issue": "10", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2014, 10, 1]], "date-time": "2014-10-01T00:00:00Z", "timestamp": 1412121600000}, "delay-in-days": 0, "content-version": "tdm"}], "funder": [{"name": "NSF CMMI MDSE", "award": ["#0727984"]}, {"name": "NSF CBET BBBE", "award": ["#0700764"]}], "content-domain": {"domain": ["bmn.com", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Drug Discovery Today"], "published-print": {"date-parts": [[2014, 10]]}, "DOI": "10.1016/j.drudis.2014.05.003", "type": "journal-article", "created": {"date-parts": [[2014, 5, 20]], "date-time": "2014-05-20T08:15:11Z", "timestamp": 1400573711000}, "page": "1587-1594", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 17, "title": ["Three dimensional human small intestine models for ADME-Tox studies"], "prefix": "10.1016", "volume": "19", "author": [{"given": "Jiajie", "family": "Yu", "sequence": "first", "affiliation": []}, {"given": "Rebecca L.", "family": "Carrier", "sequence": "additional", "affiliation": []}, {"given": "John C.", "family": "March", "sequence": "additional", "affiliation": []}, {"given": "Linda G.", "family": "Griffith", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Drug Discovery Today"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1359644614001779?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1359644614001779?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 8, 10]], "date-time": "2019-08-10T16:41:40Z", "timestamp": 1565455300000}, "score": 39.040096, "issued": {"date-parts": [[2014, 10]]}, "references-count": 66, "journal-issue": {"published-print": {"date-parts": [[2014, 10]]}, "issue": "10"}, "alternative-id": ["S1359644614001779"], "URL": "http://dx.doi.org/10.1016/j.drudis.2014.05.003", "ISSN": ["1359-6446"], "issn-type": [{"value": "1359-6446", "type": "print"}], "subject": ["Pharmacology", "Drug Discovery"], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Three dimensional human small intestine models for ADME-Tox studies", "name": "articletitle", "label": "Article Title"}, {"value": "Drug Discovery Today", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.drudis.2014.05.003", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "Copyright \u00a9 2014 Published by Elsevier Ltd.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T02:33:22Z", "timestamp": 1574476402266}, "publisher-location": "Hoboken, NJ, USA", "reference-count": 48, "publisher": "John Wiley & Sons, Inc.", "isbn-type": [{"value": "9780470542781", "type": "print"}, {"value": "9781118180778", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1002/9781118180778.ch11", "type": "book-chapter", "created": {"date-parts": [[2012, 5, 16]], "date-time": "2012-05-16T03:06:24Z", "timestamp": 1337137584000}, "page": "169-175", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Methods for Assessing Blood-Brain Barrier Penetration in Drug Discovery"], "prefix": "10.1002", "author": [{"given": "Li", "family": "Di", "sequence": "first", "affiliation": []}, {"given": "Edward H.", "family": "Kerns", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2012, 5, 15]]}, "reference": [{"key": "10.1002/9781118180778.ch11-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/S1359-6446(00)01583-X", "article-title": "Crossing the blood-brain barrier: Are we getting it right?", "volume": "6", "author": "Pardridge", "year": "2001", "journal-title": "Drug Discov Today"}, {"key": "10.1002/9781118180778.ch11-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "711", "DOI": "10.1038/nrd1470", "article-title": "Opinion: Can the pharmaceutical industry reduce attrition rates?", "volume": "3", "author": "Kola", "year": "2004", "journal-title": "Nat Rev Drug Discov"}, {"key": "10.1002/9781118180778.ch11-BIB3|cit3", "author": "Audus", "year": "2002", "volume-title": "Designing Drugs to Minimize or Maximize Exposure to the Brain"}, {"key": "10.1002/9781118180778.ch11-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "5", "DOI": "10.1016/0169-409X(95)00003-P", "article-title": "Transport of small molecules through the blood-brain barrier: Biology and methodology", "volume": "15", "author": "Pardridge", "year": "1995", "journal-title": "Adv Drug Deliv Rev"}, {"key": "10.1002/9781118180778.ch11-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "677", "DOI": "10.1517/17460441.3.6.677", "article-title": "Strategies to assess blood-brain barrier penetration", "volume": "3", "author": "Di", "year": "2008", "journal-title": "Expert Opin Drug Discov"}, {"key": "10.1002/9781118180778.ch11-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "223", "DOI": "10.1016/S0223-5234(03)00012-6", "article-title": "High throughput artificial membrane permeability assay for blood-brain barrier", "volume": "38", "author": "Di", "year": "2003", "journal-title": "Eur J Med Chem"}, {"key": "10.1002/9781118180778.ch11-BIB7|cit7", "first-page": "505", "article-title": "Strategies to optimize brain penetration in drug discovery", "volume": "8", "author": "Liu", "year": "2005", "journal-title": "Curr Opin Drug Discov Devel"}, {"issue": "8", "key": "10.1002/9781118180778.ch11-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "1737", "DOI": "10.1007/s11095-007-9502-2", "article-title": "On the rate and extent of drug delivery to the brain", "volume": "25", "author": "Hammarlund-Udenaes", "year": "2008", "journal-title": "Pharm Res"}, {"key": "10.1002/9781118180778.ch11-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "337", "DOI": "10.1517/17425250903559873", "article-title": "Assessing brain free fraction in early drug discovery", "volume": "6", "author": "Read", "year": "2010", "journal-title": "Expert Opin Drug Metab Toxicol"}, {"key": "10.1002/9781118180778.ch11-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "215", "DOI": "10.1111/j.1742-7843.2009.00517.x", "article-title": "Active-site concentrations of chemicals - Are they a better predictor of effect than plasma/organ/tissue concentrations?", "volume": "106", "author": "Hammarlund-Udenaes", "year": "2010", "journal-title": "Basic Clin Pharmacol Toxicol"}, {"issue": "12", "key": "10.1002/9781118180778.ch11-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "929", "DOI": "10.1038/nrd3287", "article-title": "The effect of plasma protein binding on in vivo efficacy: Misconceptions in drug discovery", "volume": "9", "author": "Smith", "year": "2010", "journal-title": "Nat Rev Drug Discov"}, {"key": "10.1002/9781118180778.ch11-BIB12|cit12", "author": "Kerns", "year": "2008", "volume-title": "Drug-like Properties: Concepts, Structure Design and Methods: From ADME to Toxicity Optimization"}, {"key": "10.1002/9781118180778.ch11-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "1681", "DOI": "10.1002/jps.1119", "article-title": "Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier", "volume": "90", "author": "Gumbleton", "year": "2001", "journal-title": "J Pharm Sci"}, {"key": "10.1002/9781118180778.ch11-BIB14|cit14", "first-page": "884", "article-title": "Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier", "volume": "253", "author": "Pardridge", "year": "1990", "journal-title": "J Pharmacol Exp Ther"}, {"key": "10.1002/9781118180778.ch11-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "148", "DOI": "10.2174/156802609787521607", "article-title": "Methodologies to assess brain drug delivery in lead optimization", "volume": "9", "author": "Hammarlund-Udenaes", "year": "2009", "journal-title": "Curr Top Med Chem"}, {"key": "10.1002/9781118180778.ch11-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "1548", "DOI": "10.1124/dmd.109.026674", "article-title": "Unbound brain concentration determines receptor occupancy: A correlation of drug concentration and brain serotonin and dopamine reuptake transporter occupancy for eighteen compounds in rats", "volume": "37", "author": "Liu", "year": "2009", "journal-title": "Drug Metab Dispos"}, {"key": "10.1002/9781118180778.ch11-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1016/S0165-0173(97)00014-3", "article-title": "Methodological considerations of intracerebral microdialysis in pharmacokinetic studies on drug transport across the blood-brain barrier", "volume": "25", "author": "de Lange", "year": "1997", "journal-title": "Brain Res Rev"}, {"key": "10.1002/9781118180778.ch11-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "128", "DOI": "10.1023/A:1012080106490", "article-title": "Drug equilibration across the blood-brain barrier - Pharmacokinetic considerations based on the microdialysis method", "volume": "14", "author": "Hammarlund-Udenaes", "year": "1997", "journal-title": "Pharm Res"}, {"key": "10.1002/9781118180778.ch11-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "267", "DOI": "10.1023/A:1012081501464", "article-title": "Application of microdialysis in pharmacokinetic studies", "volume": "14", "author": "Elmquist", "year": "1997", "journal-title": "Pharm Res"}, {"key": "10.1002/9781118180778.ch11-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "283", "DOI": "10.1016/S0169-409X(00)00109-5", "article-title": "The use of microdialysis in CNS drug delivery studies. Pharmacokinetic perspectives and results with analgesics and antiepileptics", "volume": "45", "author": "Hammarlund-Udenaes", "year": "2000", "journal-title": "Adv Drug Deliv Rev"}, {"key": "10.1002/9781118180778.ch11-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "1391", "DOI": "10.1021/ac0693722", "article-title": "In vivo measurements of neurotransmitters by microdialysis sampling", "volume": "78", "author": "Watson", "year": "2006", "journal-title": "Anal Chem"}, {"key": "10.1002/9781118180778.ch11-BIB22|cit22", "doi-asserted-by": "crossref", "first-page": "351", "DOI": "10.1002/bdd.328", "article-title": "Investigation of the high partition of YM992, a novel antidepressant, in rat brain - In vitro and in vivo evidence for the high binding in brain and the high permeability at the BBB", "volume": "23", "author": "Mano", "year": "2002", "journal-title": "Biopharm Drug Dispos"}, {"key": "10.1002/9781118180778.ch11-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "327", "DOI": "10.1002/bdd.325", "article-title": "Influence of nonspecific brain and plasma binding on CNS exposure: Implications for rational drug discovery", "volume": "23", "author": "Kalvass", "year": "2002", "journal-title": "Biopharm Drug Dispos"}, {"key": "10.1002/9781118180778.ch11-BIB24|cit24", "doi-asserted-by": "crossref", "first-page": "175", "DOI": "10.1124/dmd.104.001222", "article-title": "Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice", "volume": "33", "author": "Maurer", "year": "2005", "journal-title": "Drug Metab Dispos"}, {"key": "10.1002/9781118180778.ch11-BIB25|cit25", "doi-asserted-by": "crossref", "first-page": "787", "DOI": "10.1124/dmd.108.024125", "article-title": "Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid", "volume": "37", "author": "Liu", "year": "2009", "journal-title": "Drug Metab Dispos"}, {"key": "10.1002/9781118180778.ch11-BIB26|cit26", "doi-asserted-by": "crossref", "first-page": "1282", "DOI": "10.1124/jpet.105.092916", "article-title": "Improving the in vitro prediction of in vivo central nervous system penetration: Integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain", "volume": "316", "author": "Summerfield", "year": "2006", "journal-title": "J Pharmacol Exp Ther"}, {"key": "10.1002/9781118180778.ch11-BIB27|cit27", "doi-asserted-by": "crossref", "first-page": "4606", "DOI": "10.1021/jm070375w", "article-title": "High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery", "volume": "50", "author": "Wan", "year": "2007", "journal-title": "J Med Chem"}, {"key": "10.1002/9781118180778.ch11-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "855", "DOI": "10.1124/dmd.105.007914", "article-title": "Evaluation of the utility of brain slice methods to study brain penetration", "volume": "34", "author": "Becker", "year": "2006", "journal-title": "Drug Metab Dispos"}, {"key": "10.1002/9781118180778.ch11-BIB29|cit29", "doi-asserted-by": "crossref", "first-page": "1226", "DOI": "10.1124/dmd.108.026377", "article-title": "Development of a high-throughput brain slice method for studying drug distribution in the central nervous system", "volume": "37", "author": "Friden", "year": "2009", "journal-title": "Drug Metab Dispos"}, {"key": "10.1002/9781118180778.ch11-BIB30|cit30", "doi-asserted-by": "crossref", "first-page": "1711", "DOI": "10.1124/dmd.107.015222", "article-title": "In vitro methods for estimating unbound drug concentrations in the brain interstitial and intracellular fluids", "volume": "35", "author": "Friden", "year": "2007", "journal-title": "Drug Metab Dispos"}, {"key": "10.1002/9781118180778.ch11-BIB31|cit31", "doi-asserted-by": "crossref", "first-page": "115", "DOI": "10.1067/mcp.2002.121829", "article-title": "Changes in plasma protein binding have little clinical relevance", "volume": "71", "author": "Benet", "year": "2002", "journal-title": "Clin Pharmacol Ther"}, {"key": "10.1002/9781118180778.ch11-BIB32|cit32", "doi-asserted-by": "crossref", "first-page": "1825", "DOI": "10.1016/j.addr.2004.07.011", "article-title": "Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics", "volume": "56", "author": "Shen", "year": "2004", "journal-title": "Adv Drug Deliv Rev"}, {"key": "10.1002/9781118180778.ch11-BIB33|cit33", "doi-asserted-by": "crossref", "first-page": "46", "DOI": "10.2174/138920008783331077", "article-title": "CSF as a surrogate for assessing CNS exposure: An industrial perspective", "volume": "9", "author": "Lin", "year": "2008", "journal-title": "Curr Drug Metab"}, {"key": "10.1002/9781118180778.ch11-BIB34|cit34", "doi-asserted-by": "crossref", "first-page": "6233", "DOI": "10.1021/jm901036q", "article-title": "Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids", "volume": "52", "author": "Friden", "year": "2009", "journal-title": "J Med Chem"}, {"key": "10.1002/9781118180778.ch11-BIB35|cit35", "doi-asserted-by": "crossref", "first-page": "1443", "DOI": "10.1124/dmd.105.008201", "article-title": "Evaluation of cerebrospinal fluid concentration and plasma free concentration as a surrogate measurement for brain free concentration", "volume": "34", "author": "Liu", "year": "2006", "journal-title": "Drug Metab Dispos"}, {"key": "10.1002/9781118180778.ch11-BIB36|cit36", "first-page": "H484", "article-title": "An in situ brain perfusion technique to study cerebrovascular transport in the rat", "volume": "247", "author": "Takasato", "year": "1984", "journal-title": "Am J Physiol"}, {"key": "10.1002/9781118180778.ch11-BIB37|cit37", "first-page": "209", "article-title": "In situ brain perfusion technique", "volume": "89", "author": "Smith", "year": "2003", "journal-title": "Methods Mol Med"}, {"key": "10.1002/9781118180778.ch11-BIB38|cit38", "doi-asserted-by": "crossref", "first-page": "205", "DOI": "10.1124/jpet.107.121525", "article-title": "Central nervous system drug disposition: The relationship between in situ brain permeability and brain free fraction", "volume": "322", "author": "Summerfield", "year": "2007", "journal-title": "J Pharmacol Exp Ther"}, {"key": "10.1002/9781118180778.ch11-BIB39|cit39", "doi-asserted-by": "crossref", "first-page": "1980", "DOI": "10.1002/jps.21580", "article-title": "Comparison of blood-brain barrier permeability assays: In situ brain perfusion, MDR1-MDCKII and PAMPA-BBB", "volume": "98", "author": "Di", "year": "2009", "journal-title": "J Pharm Sci"}, {"key": "10.1002/9781118180778.ch11-BIB40|cit40", "doi-asserted-by": "crossref", "first-page": "299", "DOI": "10.1016/j.tiv.2004.06.011", "article-title": "In vitro models for the blood-brain barrier", "volume": "19", "author": "Garberg", "year": "2005", "journal-title": "Toxicol In Vitro"}, {"key": "10.1002/9781118180778.ch11-BIB41|cit41", "doi-asserted-by": "crossref", "first-page": "650", "DOI": "10.1038/nrd2368", "article-title": "Modelling of the blood-brain barrier in drug discovery and development", "volume": "6", "author": "Cecchelli", "year": "2007", "journal-title": "Nat Rev Drug Discov"}, {"key": "10.1002/9781118180778.ch11-BIB42|cit42", "doi-asserted-by": "crossref", "first-page": "945", "DOI": "10.1016/S0731-7085(01)00542-8", "article-title": "Comparison of in vitro BBMEC permeability and in vivo CNS uptake by microdialysis sampling", "volume": "27", "author": "Hansen", "year": "2002", "journal-title": "J Pharm Biomed Anal"}, {"key": "10.1002/9781118180778.ch11-BIB43|cit43", "first-page": "998", "article-title": "Comparison of drug efflux transport kinetics in various blood-brain barrier models", "volume": "34", "author": "Bachmeier", "year": "2006", "journal-title": "Drug Metab Dispos"}, {"key": "10.1002/9781118180778.ch11-BIB44|cit44", "doi-asserted-by": "crossref", "first-page": "132", "DOI": "10.1124/dmd.32.1.132", "article-title": "Development of a computational approach to predict blood-brain barrier permeability", "volume": "32", "author": "Liu", "year": "2004", "journal-title": "Drug Metab Dispos"}, {"key": "10.1002/9781118180778.ch11-BIB45|cit45", "doi-asserted-by": "crossref", "first-page": "215", "DOI": "10.1038/nrd3028", "article-title": "Membrane transporters in drug development", "volume": "9", "author": "Giacomini", "year": "2010", "journal-title": "Nat Rev Drug Discov"}, {"key": "10.1002/9781118180778.ch11-BIB46|cit46", "doi-asserted-by": "crossref", "first-page": "165", "DOI": "10.1124/dmd.104.001230", "article-title": "The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: Evaluation using the MDR1A/1B knockout mouse model", "volume": "33", "author": "Doran", "year": "2005", "journal-title": "Drug Metab Dispos"}, {"issue": "2", "key": "10.1002/9781118180778.ch11-BIB47|cit47", "doi-asserted-by": "crossref", "first-page": "349", "DOI": "10.1124/jpet.107.130294", "article-title": "Progress in brain penetration evaluation in drug discovery and development", "volume": "325", "author": "Liu", "year": "2008", "journal-title": "J Pharmacol Exp Ther"}, {"key": "10.1002/9781118180778.ch11-BIB48|cit48", "first-page": "620", "article-title": "Rational use of in vitro P-glycoprotein assays in drug discovery", "volume": "299", "author": "Polli", "year": "2001", "journal-title": "J Pharmacol Exp Ther"}], "container-title": ["ADME-Enabling Technologies in Drug Design and Development"], "deposited": {"date-parts": [[2017, 6, 20]], "date-time": "2017-06-20T18:48:42Z", "timestamp": 1497984522000}, "score": 37.430595, "issued": {"date-parts": [[2012, 5, 15]]}, "ISBN": ["9781118180778", "9780470542781"], "references-count": 48, "URL": "http://dx.doi.org/10.1002/9781118180778.ch11", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T02:33:42Z", "timestamp": 1574476422358}, "publisher-location": "Hoboken, NJ, USA", "reference-count": 163, "publisher": "John Wiley & Sons, Inc.", "isbn-type": [{"value": "9780470542781", "type": "print"}, {"value": "9781118180778", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1002/9781118180778.ch28", "type": "book-chapter", "created": {"date-parts": [[2012, 5, 16]], "date-time": "2012-05-16T03:06:24Z", "timestamp": 1337137584000}, "page": "235-454", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Genetically Modified Mouse Models in ADME Studies"], "prefix": "10.1002", "author": [{"given": "Xi-Ling", "family": "Jiang", "sequence": "first", "affiliation": []}, {"given": "Ai-Ming", "family": "Yu", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2012, 5, 15]]}, "reference": [{"key": "10.1002/9781118180778.ch28-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "481", "DOI": "10.1124/mol.109.056564", "article-title": "Toward a systems level understanding of organic anion and other multispecific drug transporters: A remote sensing and signaling hypothesis", "volume": "76", "author": "Ahn", "year": "2009", "journal-title": "Mol Pharmacol"}, {"key": "10.1002/9781118180778.ch28-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "689", "DOI": "10.1177/153537020523001001", "article-title": "Biology of a novel organic solute and steroid transporter, OSTalpha-OSTbeta", "volume": "230", "author": "Ballatori", "year": "2005", "journal-title": "Exp Biol Med (Maywood)"}, {"key": "10.1002/9781118180778.ch28-BIB3|cit3", "first-page": "160", "article-title": "Analysis of the in vivo functions of Mrp3", "volume": "68", "author": "Belinsky", "year": "2005", "journal-title": "Mol Pharmacol"}, {"key": "10.1002/9781118180778.ch28-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "1097", "DOI": "10.1345/aph.1E614", "article-title": "Transporters and their impact on drug disposition", "volume": "39", "author": "Beringer", "year": "2005", "journal-title": "Ann Pharmacother"}, {"key": "10.1002/9781118180778.ch28-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "1131", "DOI": "10.1080/00498250010021684", "article-title": "Determining the best animal model for human cytochrome P450 activities: A comparison of mouse, rat, rabbit, dog, micropig, monkey and man", "volume": "30", "author": "Bogaards", "year": "2000", "journal-title": "Xenobiotica"}, {"key": "10.1002/9781118180778.ch28-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "349", "DOI": "10.1002/hep.21481", "article-title": "The role of chrysin and the ah receptor in induction of the human UGT1A1 gene in vitro and in transgenic UGT1 mice", "volume": "45", "author": "Bonzo", "year": "2007", "journal-title": "Hepatology"}, {"key": "10.1002/9781118180778.ch28-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "537", "DOI": "10.1146/annurev.biochem.71.102301.093055", "article-title": "Mammalian ABC transporters in health and disease", "volume": "71", "author": "Borst", "year": "2002", "journal-title": "Annu Rev Biochem"}, {"key": "10.1002/9781118180778.ch28-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "347", "DOI": "10.1016/S0005-2736(99)00167-4", "article-title": "The multidrug resistance protein family", "volume": "1461", "author": "Borst", "year": "1999", "journal-title": "Biochim Biophys Acta"}, {"key": "10.1002/9781118180778.ch28-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "661", "DOI": "10.1007/s00424-006-0054-9", "article-title": "Multidrug resistance-associated proteins 3, 4, and 5", "volume": "453", "author": "Borst", "year": "2007", "journal-title": "Pfl ugers Arch"}, {"key": "10.1002/9781118180778.ch28-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "2577", "DOI": "10.1158/0008-5472.CAN-04-2416", "article-title": "The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): Implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients", "volume": "65", "author": "Breedveld", "year": "2005", "journal-title": "Cancer Res"}, {"key": "10.1002/9781118180778.ch28-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "291", "DOI": "10.1097/00008571-199608000-00002", "article-title": "Role of CYP1A2 in caffeine pharmacokinetics and metabolism: Studies using mice deficient in CYP1A2", "volume": "6", "author": "Buters", "year": "1996", "journal-title": "Pharmacogenetics"}, {"key": "10.1002/9781118180778.ch28-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "1977", "DOI": "10.1073/pnas.96.5.1977", "article-title": "Cytochrome P450 CYP1B1 determines susceptibility to 7,12-dimethylbenz[a]anthracene-induced lymphomas", "volume": "96", "author": "Buters", "year": "1999", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "10.1002/9781118180778.ch28-BIB13|cit13", "first-page": "657", "article-title": "CYP2E1 - Biochemical and toxicological aspects and role in alcohol-induced liver injury", "volume": "73", "author": "Cederbaum", "year": "2006", "journal-title": "Mt Sinai J Med"}, {"key": "10.1002/9781118180778.ch28-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "1840", "DOI": "10.1124/dmd.108.020594", "article-title": "Utility of a novel Oatp1b2 knockout mouse model for evaluating the role of Oatp1b2 in the hepatic uptake of model compounds", "volume": "36", "author": "Chen", "year": "2008", "journal-title": "Drug Metab Dispos"}, {"key": "10.1002/9781118180778.ch28-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "37547", "DOI": "10.1074/jbc.M506683200", "article-title": "Tissue-specific, inducible, and hormonal control of the human UDP-glucuronosyltransferase-1 (UGT1) locus", "volume": "280", "author": "Chen", "year": "2005", "journal-title": "J Biol Chem"}, {"key": "10.1002/9781118180778.ch28-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "288", "DOI": "10.1124/jpet.108.141242", "article-title": "Humanized mouse lines and their application for prediction of human drug metabolism and toxicological risk assessment", "volume": "327", "author": "Cheung", "year": "2008", "journal-title": "J Pharmacol Exp Ther"}, {"key": "10.1002/9781118180778.ch28-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "3849", "DOI": "10.1158/0008-5472.CAN-04-0322", "article-title": "Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha", "volume": "64", "author": "Cheung", "year": "2004", "journal-title": "Cancer Res"}, {"key": "10.1002/9781118180778.ch28-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "1471", "DOI": "10.1021/tx050136g", "article-title": "Differential metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in mice humanized for CYP1A1 and CYP1A2", "volume": "18", "author": "Cheung", "year": "2005a", "journal-title": "Chem Res Toxicol"}, {"key": "10.1002/9781118180778.ch28-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "449", "DOI": "10.1124/dmd.104.002402", "article-title": "The cyp2e1-humanized transgenic mouse: Role of cyp2e1 in acetaminophen hepatotoxicity", "volume": "33", "author": "Cheung", "year": "2005b", "journal-title": "Drug Metab Dispos"}, {"key": "10.1002/9781118180778.ch28-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "1328", "DOI": "10.1124/jpet.105.094367", "article-title": "Growth hormone determines sexual dimorphism of hepatic cytochrome P450 3A4 expression in transgenic mice", "volume": "316", "author": "Cheung", "year": "2006", "journal-title": "J Pharmacol Exp Ther"}, {"key": "10.1002/9781118180778.ch28-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "579", "DOI": "10.1124/jpet.105.098665", "article-title": "Characterization of mice lacking the multidrug resistance protein MRP2 (ABCC2)", "volume": "317", "author": "Chu", "year": "2006", "journal-title": "J Pharmacol Exp Ther"}, {"key": "10.1002/9781118180778.ch28-BIB22|cit22", "doi-asserted-by": "crossref", "first-page": "H1586", "DOI": "10.1152/ajpheart.00867.2008", "article-title": "Glutathione-S-transferase P protects against endothelial dysfunction induced by exposure to tobacco smoke", "volume": "296", "author": "Conklin", "year": "2009", "journal-title": "Am J Physiol Heart Circ Physiol"}, {"key": "10.1002/9781118180778.ch28-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "1260", "DOI": "10.1124/mol.60.6.1260", "article-title": "The CYP2D6 humanized mouse: Effect of the human CYP2D6 transgene and HNF4alpha on the disposition of debrisoquine in the mouse", "volume": "60", "author": "Corchero", "year": "2001", "journal-title": "Mol Pharmacol"}, {"key": "10.1002/9781118180778.ch28-BIB24|cit24", "doi-asserted-by": "crossref", "first-page": "341", "DOI": "10.2174/1389200054633862", "article-title": "Animal models of xenobiotic receptors", "volume": "6", "author": "Dai", "year": "2005", "journal-title": "Curr Drug Metab"}, {"key": "10.1002/9781118180778.ch28-BIB25|cit25", "first-page": "1590", "article-title": "Retinoid X receptor alpha regulates the expression of glutathione S-transferase genes and modulates acetaminophen-glutathione conjugation in mouse liver", "volume": "68", "author": "Dai", "year": "2005", "journal-title": "Mol Pharmacol"}, {"key": "10.1002/9781118180778.ch28-BIB26|cit26", "doi-asserted-by": "crossref", "first-page": "184", "DOI": "10.1006/bbrc.1999.1913", "article-title": "Targeted knockout of Cyp1a1 gene does not alter hepatic constitutive expression of other genes in the mouse [Ah] battery", "volume": "267", "author": "Dalton", "year": "2000", "journal-title": "Biochem Biophys Res Commun"}, {"key": "10.1002/9781118180778.ch28-BIB27|cit27", "doi-asserted-by": "crossref", "first-page": "503", "DOI": "10.1097/01.fpc.0000167326.00411.50", "article-title": "Theophylline pharmacokinetics: Comparison of Cyp1a1(-/-) and Cyp1a2(-/-) knockout mice, humanized hCYP1A1_1A2 knock-in mice lacking either the mouse Cyp1a1 or Cyp1a2 gene, and Cyp1(+/+) wild-type mice", "volume": "15", "author": "Derkenne", "year": "2005", "journal-title": "Pharmacogenet Genomics"}, {"key": "10.1002/9781118180778.ch28-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "635", "DOI": "10.1016/j.bbrc.2007.05.202", "article-title": "Generation of \u201chumanized\u201d hCYP1A1_1A2_Cyp1a1/1a2(-/-) mouse line", "volume": "359", "author": "Dragin", "year": "2007", "journal-title": "Biochem Biophys Res Commun"}, {"key": "10.1002/9781118180778.ch28-BIB29|cit29", "doi-asserted-by": "crossref", "first-page": "5072", "DOI": "10.1074/jbc.M508050200", "article-title": "Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knock-out mice", "volume": "281", "author": "Eraly", "year": "2006", "journal-title": "J Biol Chem"}, {"key": "10.1002/9781118180778.ch28-BIB30|cit30", "doi-asserted-by": "crossref", "first-page": "48", "DOI": "10.1016/j.taap.2007.10.014", "article-title": "Mechanism of chloroform-induced renal toxicity: Non-involvement of hepatic cytochrome P450-dependent metabolism", "volume": "227", "author": "Fang", "year": "2008a", "journal-title": "Toxicol Appl Pharmacol"}, {"key": "10.1002/9781118180778.ch28-BIB31|cit31", "doi-asserted-by": "crossref", "first-page": "1722", "DOI": "10.1124/dmd.108.021881", "article-title": "Deletion of the NADPH-cytochrome P450 reductase gene in cardiomyocytes does not protect mice against doxorubicin-mediated acute cardiac toxicity", "volume": "36", "author": "Fang", "year": "2008b", "journal-title": "Drug Metab Dispos"}, {"key": "10.1002/9781118180778.ch28-BIB32|cit32", "doi-asserted-by": "crossref", "first-page": "435", "DOI": "10.1124/dmd.107.018838", "article-title": "Cytochrome P450 expression and regulation in CYP3A4/CYP2D6 double transgenic humanized mice", "volume": "36", "author": "Felmlee", "year": "2008", "journal-title": "Drug Metab Dispos"}, {"key": "10.1002/9781118180778.ch28-BIB33|cit33", "doi-asserted-by": "crossref", "first-page": "722", "DOI": "10.1126/science.7732381", "article-title": "Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor", "volume": "268", "author": "Fernandez-Salguero", "year": "1995", "journal-title": "Science"}, {"key": "10.1002/9781118180778.ch28-BIB34|cit34", "doi-asserted-by": "crossref", "first-page": "40", "DOI": "10.1124/jpet.107.121780", "article-title": "Conditional deletion of cytochrome P450 oxidoreductase in the liver and gastrointestinal tract: A new model for studying the functions of the P450 system", "volume": "322", "author": "Finn", "year": "2007", "journal-title": "J Pharmacol Exp Ther"}, {"key": "10.1002/9781118180778.ch28-BIB35|cit35", "doi-asserted-by": "crossref", "first-page": "760", "DOI": "10.1124/pr.58.4.7", "article-title": "International union of pharmacology. LXIII. Retinoid X receptors", "volume": "58", "author": "Germain", "year": "2006", "journal-title": "Pharmacol Rev"}, {"key": "10.1002/9781118180778.ch28-BIB36|cit36", "doi-asserted-by": "crossref", "first-page": "2", "DOI": "10.1016/j.tox.2007.09.030", "article-title": "PPARalpha: Mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators", "volume": "246", "author": "Gonzalez", "year": "2008", "journal-title": "Toxicology"}, {"key": "10.1002/9781118180778.ch28-BIB37|cit37", "doi-asserted-by": "crossref", "first-page": "41", "DOI": "10.1146/annurev.pharmtox.45.120403.100007", "article-title": "Cytochrome P450 and xenobiotic receptor humanized mice", "volume": "46", "author": "Gonzalez", "year": "2006", "journal-title": "Annu Rev Pharmacol Toxicol"}, {"key": "10.1002/9781118180778.ch28-BIB38|cit38", "doi-asserted-by": "crossref", "first-page": "548", "DOI": "10.1124/dmd.31.5.548", "article-title": "Expression of the human CYP3A4 gene in the small intestine of transgenic mice: In vitro metabolism and pharmacokinetics of midazolam", "volume": "31", "author": "Granvil", "year": "2003", "journal-title": "Drug Metab Dispos"}, {"key": "10.1002/9781118180778.ch28-BIB39|cit39", "doi-asserted-by": "crossref", "first-page": "25895", "DOI": "10.1074/jbc.M303125200", "article-title": "Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: Impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase", "volume": "278", "author": "Gu", "year": "2003", "journal-title": "J Biol Chem"}, {"key": "10.1002/9781118180778.ch28-BIB40|cit40", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1124/jpet.106.118240", "article-title": "A mouse model with liver-specific deletion and global suppression of the NADPH-cytochrome P450 reductase gene: Characterization and utility for in vivo studies of cyclophosphamide disposition", "volume": "321", "author": "Gu", "year": "2007", "journal-title": "J Pharmacol Exp Ther"}, {"key": "10.1002/9781118180778.ch28-BIB41|cit41", "doi-asserted-by": "crossref", "first-page": "1729", "DOI": "10.1101/gr.3728305", "article-title": "The mouse genome", "volume": "15", "author": "Guenet", "year": "2005", "journal-title": "Genome Res"}, {"key": "10.1002/9781118180778.ch28-BIB42|cit42", "doi-asserted-by": "crossref", "first-page": "E101", "DOI": "10.1208/aapsj080112", "article-title": "Cytochrome P450s and other enzymes in drug metabolism and toxicity", "volume": "8", "author": "Guengerich", "year": "2006", "journal-title": "AAPS J"}, {"key": "10.1002/9781118180778.ch28-BIB43|cit43", "doi-asserted-by": "crossref", "first-page": "331", "DOI": "10.1124/mi.3.6.331", "article-title": "Transgenic analysis of human drug-metabolizing enzymes: Preclinical drug development and toxicology", "volume": "3", "author": "Henderson", "year": "2003", "journal-title": "Mol Interv"}, {"key": "10.1002/9781118180778.ch28-BIB44|cit44", "doi-asserted-by": "crossref", "first-page": "5275", "DOI": "10.1073/pnas.95.9.5275", "article-title": "Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases", "volume": "95", "author": "Henderson", "year": "1998", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "10.1002/9781118180778.ch28-BIB45|cit45", "doi-asserted-by": "crossref", "first-page": "12741", "DOI": "10.1073/pnas.220176997", "article-title": "Increased resistance to acetaminophen hepatotoxicity in mice lacking glutathione S-transferase pi", "volume": "97", "author": "Henderson", "year": "2000", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "10.1002/9781118180778.ch28-BIB46|cit46", "doi-asserted-by": "crossref", "first-page": "13480", "DOI": "10.1074/jbc.M212087200", "article-title": "Inactivation of the hepa tic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase", "volume": "278", "author": "Henderson", "year": "2003", "journal-title": "J Biol Chem"}, {"key": "10.1002/9781118180778.ch28-BIB47|cit47", "doi-asserted-by": "crossref", "first-page": "111", "DOI": "10.1016/j.toxlet.2005.10.016", "article-title": "The hepatic cytochrome P450 reductase null mouse as a tool to identify a successful candidate entity", "volume": "162", "author": "Henderson", "year": "2006", "journal-title": "Toxicol Lett"}, {"key": "10.1002/9781118180778.ch28-BIB48|cit48", "first-page": "6447", "article-title": "The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine", "volume": "63", "author": "van Herwaarden", "year": "2003", "journal-title": "Cancer Res"}, {"key": "10.1002/9781118180778.ch28-BIB49|cit49", "doi-asserted-by": "crossref", "first-page": "892", "DOI": "10.1124/dmd.105.004721", "article-title": "Midazolam and cyclosporin a metabolism in transgenic mice with liver-specific expression of human CYP3A4", "volume": "33", "author": "van Herwaarden", "year": "2005", "journal-title": "Drug Metab Dispos"}, {"key": "10.1002/9781118180778.ch28-BIB50|cit50", "doi-asserted-by": "crossref", "first-page": "3583", "DOI": "10.1172/JCI33435", "article-title": "Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism", "volume": "117", "author": "van Herwaarden", "year": "2007", "journal-title": "J Clin Invest"}, {"key": "10.1002/9781118180778.ch28-BIB51|cit51", "doi-asserted-by": "crossref", "first-page": "2402", "DOI": "10.1210/me.2004-0046", "article-title": "Meclizine is an agonist ligand for mouse constitutive androstane receptor (CAR) and an inverse agonist for human CAR", "volume": "18", "author": "Huang", "year": "2004", "journal-title": "Mol Endocrinol"}, {"key": "10.1002/9781118180778.ch28-BIB52|cit52", "doi-asserted-by": "crossref", "first-page": "619", "DOI": "10.1124/mol.106.028233", "article-title": "Functional involvement of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir", "volume": "71", "author": "Imaoka", "year": "2007", "journal-title": "Mol Pharmacol"}, {"key": "10.1002/9781118180778.ch28-BIB53|cit53", "doi-asserted-by": "crossref", "first-page": "496", "DOI": "10.1016/j.pharmthera.2007.09.004", "article-title": "Infl uence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects", "volume": "116", "author": "Ingelman-Sundberg", "year": "2007", "journal-title": "Pharmacol Ther"}, {"key": "10.1002/9781118180778.ch28-BIB54|cit54", "doi-asserted-by": "crossref", "first-page": "443", "DOI": "10.1124/dmd.108.025056", "article-title": "Pinoline may be used as a probe for CYP2D6 activity", "volume": "37", "author": "Jiang", "year": "2009", "journal-title": "Drug Metab Dispos"}, {"key": "10.1002/9781118180778.ch28-BIB55|cit55", "doi-asserted-by": "crossref", "first-page": "196", "DOI": "10.1002/humu.20134", "article-title": "Toward the evaluation of function in genetic variability: Characterizing human SNP frequencies and establishing BAC-transgenic mice carrying the human CYP1A1_CYP1A2 locus", "volume": "25", "author": "Jiang", "year": "2005", "journal-title": "Hum Mutat"}, {"key": "10.1002/9781118180778.ch28-BIB56|cit56", "doi-asserted-by": "crossref", "first-page": "5471", "DOI": "10.1128/MCB.21.16.5471-5477.2001", "article-title": "Reduced hepatic uptake and intestinal excretion of organic cations in mice with a targeted disruption of the organic cation transporter 1 (Oct1 [Slc22a1]) gene", "volume": "21", "author": "Jonker", "year": "2001", "journal-title": "Mol Cell Biol"}, {"key": "10.1002/9781118180778.ch28-BIB57|cit57", "doi-asserted-by": "crossref", "first-page": "15649", "DOI": "10.1073/pnas.202607599", "article-title": "The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria", "volume": "99", "author": "Jonker", "year": "2002", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "10.1002/9781118180778.ch28-BIB58|cit58", "doi-asserted-by": "crossref", "first-page": "7902", "DOI": "10.1128/MCB.23.21.7902-7908.2003", "article-title": "Defi-ciency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations", "volume": "23", "author": "Jonker", "year": "2003", "journal-title": "Mol Cell Biol"}, {"key": "10.1002/9781118180778.ch28-BIB59|cit59", "doi-asserted-by": "crossref", "first-page": "127", "DOI": "10.1038/nm1186", "article-title": "The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk", "volume": "11", "author": "Jonker", "year": "2005", "journal-title": "Nat Med"}, {"key": "10.1002/9781118180778.ch28-BIB60|cit60", "doi-asserted-by": "crossref", "first-page": "236", "DOI": "10.2133/dmpk.23.236", "article-title": "Role and relevance of PEPT2 in drug disposition, dynamics, and toxicity", "volume": "23", "author": "Kamal", "year": "2008", "journal-title": "Drug Metab Pharmacokinet"}, {"key": "10.1002/9781118180778.ch28-BIB61|cit61", "doi-asserted-by": "crossref", "first-page": "987", "DOI": "10.1016/0092-8674(94)90274-7", "article-title": "Genetic analysis of RXR alpha developmental function: Convergence of RXR and RAR signaling pathways in heart and eye morphogenesis", "volume": "78", "author": "Kastner", "year": "1994", "journal-title": "Cell"}, {"key": "10.1002/9781118180778.ch28-BIB62|cit62", "doi-asserted-by": "crossref", "first-page": "97", "DOI": "10.1016/j.pharmthera.2004.10.013", "article-title": "UDP-glucuronosyltransferases and clinical drug-drug interactions", "volume": "106", "author": "Kiang", "year": "2005", "journal-title": "Pharmacol Ther"}, {"key": "10.1002/9781118180778.ch28-BIB63|cit63", "doi-asserted-by": "crossref", "first-page": "1227", "DOI": "10.1007/s11095-007-9254-z", "article-title": "Polyspecific organic cation transporters: Structure, function, physiological roles, and biopharmaceutical implications", "volume": "24", "author": "Koepsell", "year": "2007", "journal-title": "Pharm Res"}, {"key": "10.1002/9781118180778.ch28-BIB64|cit64", "doi-asserted-by": "crossref", "first-page": "1775", "DOI": "10.1002/jps.21121", "article-title": "Species differences in in vitro and in vivo small intestinal metabolism of CYP3A substrates", "volume": "97", "author": "Komura", "year": "2008", "journal-title": "J Pharm Sci"}, {"key": "10.1002/9781118180778.ch28-BIB65|cit65", "doi-asserted-by": "crossref", "first-page": "1228", "DOI": "10.1124/jpet.102.035972", "article-title": "In vitro, pharmacokinetic, and pharmacodynamic interactions of ketoconazole and midazolam in the rat", "volume": "302", "author": "Kotegawa", "year": "2002", "journal-title": "J Pharmacol Exp Ther"}, {"key": "10.1002/9781118180778.ch28-BIB66|cit66", "doi-asserted-by": "crossref", "first-page": "136", "DOI": "10.1124/mi.9.3.7", "article-title": "Pharmacokinetic assessment of multiple ATP-binding cassette transporters: The power of combination knockout mice", "volume": "9", "author": "Lagas", "year": "2009", "journal-title": "Mol Interv"}, {"key": "10.1002/9781118180778.ch28-BIB67|cit67", "doi-asserted-by": "crossref", "first-page": "3012", "DOI": "10.1128/MCB.15.6.3012", "article-title": "Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators", "volume": "15", "author": "Lee", "year": "1995", "journal-title": "Mol Cell Biol"}, {"key": "10.1002/9781118180778.ch28-BIB68|cit68", "doi-asserted-by": "crossref", "first-page": "12063", "DOI": "10.1074/jbc.271.20.12063", "article-title": "Role of CYP2E1 in the hepatotoxicity of acetaminophen", "volume": "271", "author": "Lee", "year": "1996", "journal-title": "J Biol Chem"}, {"key": "10.1002/9781118180778.ch28-BIB69|cit69", "doi-asserted-by": "crossref", "first-page": "7612", "DOI": "10.1128/MCB.24.17.7612-7621.2004", "article-title": "Mrp4 confers resistance to topotecan and protects the brain from chemotherapy", "volume": "24", "author": "Leggas", "year": "2004", "journal-title": "Mol Cell Biol"}, {"key": "10.1002/9781118180778.ch28-BIB70|cit70", "doi-asserted-by": "crossref", "first-page": "1671", "DOI": "10.1073/pnas.93.4.1671", "article-title": "Cyp1a2(-/-) null mutant mice develop normally but show deficient drug metabolism", "volume": "93", "author": "Liang", "year": "1996", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "10.1002/9781118180778.ch28-BIB71|cit71", "doi-asserted-by": "crossref", "first-page": "657", "DOI": "10.1038/nrg1429", "article-title": "Genetically modified mouse models for pharmacogenomic research", "volume": "5", "author": "Liggett", "year": "2004", "journal-title": "Nat Rev Genet"}, {"key": "10.1002/9781118180778.ch28-BIB72|cit72", "doi-asserted-by": "crossref", "first-page": "419", "DOI": "10.2174/138920008784746355", "article-title": "Applications and limitations of genetically modified mouse models in drug discovery and development", "volume": "9", "author": "Lin", "year": "2008", "journal-title": "Curr Drug Metab"}, {"key": "10.1002/9781118180778.ch28-BIB73|cit73", "doi-asserted-by": "crossref", "first-page": "99", "DOI": "10.2174/138920008783571819", "article-title": "Structure, function and polymorphism of human cytosolic sulfotransferases", "volume": "9", "author": "Lindsay", "year": "2008", "journal-title": "Curr Drug Metab"}, {"key": "10.1002/9781118180778.ch28-BIB74|cit74", "doi-asserted-by": "crossref", "first-page": "955", "DOI": "10.1124/dmd.107.019349", "article-title": "Generation of mice transgenic for human CYP2C18 and CYP2C19: Characterization of the sexually dimorphic gene and enzyme expression", "volume": "36", "author": "Lofgren", "year": "2008", "journal-title": "Drug Metab Dispos"}, {"key": "10.1002/9781118180778.ch28-BIB75|cit75", "doi-asserted-by": "crossref", "first-page": "1505", "DOI": "10.1124/dmd.109.026963", "article-title": "Regulation of human CYP2C18 and CYP2C19 in transgenic mice: Infl uence of castration, testosterone, and growth hormone", "volume": "37", "author": "Lofgren", "year": "2009", "journal-title": "Drug Metab Dispos"}, {"key": "10.1002/9781118180778.ch28-BIB76|cit76", "first-page": "5238", "article-title": "Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione", "volume": "57", "author": "Lorico", "year": "1997", "journal-title": "Cancer Res"}, {"key": "10.1002/9781118180778.ch28-BIB77|cit77", "doi-asserted-by": "crossref", "first-page": "35", "DOI": "10.1093/toxsci/kfn038", "article-title": "Characterization of organic anion transporting polypeptide 1b2-null mice: Essential role in hepatic uptake/toxicity of phalloidin and microcystin-LR", "volume": "103", "author": "Lu", "year": "2008", "journal-title": "Toxicol Sci"}, {"key": "10.1002/9781118180778.ch28-BIB78|cit78", "doi-asserted-by": "crossref", "first-page": "1009", "DOI": "10.1124/dmd.107.015826", "article-title": "CYP1A induction and human risk assessment: An evolving tale of in vitro and in vivo studies", "volume": "35", "author": "Ma", "year": "2007", "journal-title": "Drug Metab Dispos"}, {"key": "10.1002/9781118180778.ch28-BIB79|cit79", "doi-asserted-by": "crossref", "first-page": "194", "DOI": "10.1124/dmd.106.012831", "article-title": "The PREgnane X receptor gene-humanized mouse: A model for investigating drug-drug interactions mediated by cytochromes P450 3A", "volume": "35", "author": "Ma", "year": "2007", "journal-title": "Drug Metab Dispos"}, {"key": "10.1002/9781118180778.ch28-BIB80|cit80", "doi-asserted-by": "crossref", "first-page": "895", "DOI": "10.1517/17425255.4.7.895", "article-title": "The pregnane X receptor: From bench to bedside", "volume": "4", "author": "Ma", "year": "2008", "journal-title": "Expert Opin Drug Metab Toxicol"}, {"key": "10.1002/9781118180778.ch28-BIB81|cit81", "doi-asserted-by": "crossref", "first-page": "1177", "DOI": "10.1016/j.addr.2007.05.015", "article-title": "Application of allometric principles for the prediction of pharmacokinetics in human and veterinary drug development", "volume": "59", "author": "Mahmood", "year": "2007", "journal-title": "Adv Drug Deliv Rev"}, {"key": "10.1002/9781118180778.ch28-BIB82|cit82", "doi-asserted-by": "crossref", "first-page": "1091", "DOI": "10.1002/hep.20898", "article-title": "Altered disposition of acetaminophen in mice with a disruption of the Mrp3 gene", "volume": "42", "author": "Manautou", "year": "2005", "journal-title": "Hepatology"}, {"key": "10.1002/9781118180778.ch28-BIB83|cit83", "doi-asserted-by": "crossref", "first-page": "2426", "DOI": "10.1056/NEJMp0707712", "article-title": "Knock out, knock in, knock down-genetically manipulated mice and the Nobel Prize", "volume": "357", "author": "Manis", "year": "2007", "journal-title": "N Engl J Med"}, {"key": "10.1002/9781118180778.ch28-BIB84|cit84", "doi-asserted-by": "crossref", "first-page": "875", "DOI": "10.1517/17425255.2.6.875", "article-title": "Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction", "volume": "2", "author": "Martignoni", "year": "2006", "journal-title": "Expert Opin Drug Metab Toxicol"}, {"key": "10.1002/9781118180778.ch28-BIB85|cit85", "doi-asserted-by": "crossref", "first-page": "299", "DOI": "10.1080/00313020701329906", "article-title": "Glutathione S-transferase pi (GSTP1) hypermethylation in prostate cancer: Review 2007", "volume": "39", "author": "Meiers", "year": "2007", "journal-title": "Pathology"}, {"key": "10.1002/9781118180778.ch28-BIB86|cit86", "doi-asserted-by": "crossref", "first-page": "1758", "DOI": "10.1124/mol.104.010439", "article-title": "The breast cancer resistance protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoin", "volume": "67", "author": "Merino", "year": "2005", "journal-title": "Mol Pharmacol"}, {"key": "10.1002/9781118180778.ch28-BIB87|cit87", "doi-asserted-by": "crossref", "first-page": "690", "DOI": "10.1124/dmd.105.008219", "article-title": "Breast cancer resistance protein (BCRP/ABCG2) transports fl uoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion", "volume": "34", "author": "Merino", "year": "2006", "journal-title": "Drug Metab Dispos"}, {"key": "10.1002/9781118180778.ch28-BIB88|cit88", "doi-asserted-by": "crossref", "first-page": "645", "DOI": "10.1046/j.1365-2443.1997.1490345.x", "article-title": "Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor", "volume": "2", "author": "Mimura", "year": "1997", "journal-title": "Genes Cells"}, {"key": "10.1002/9781118180778.ch28-BIB89|cit89", "doi-asserted-by": "crossref", "first-page": "5652", "DOI": "10.1073/pnas.1037886100", "article-title": "Distinct response to dioxin in an aryl hydrocarbon receptor (AHR)-humanized mouse", "volume": "100", "author": "Moriguchi", "year": "2003", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "10.1002/9781118180778.ch28-BIB90|cit90", "doi-asserted-by": "crossref", "first-page": "818", "DOI": "10.1038/clpt.2008.50", "article-title": "Mice as clinically relevant models for the study of cytochrome P450-dependent metabolism", "volume": "83", "author": "Muruganandan", "year": "2008", "journal-title": "Clin Pharmacol Ther"}, {"key": "10.1002/9781118180778.ch28-BIB91|cit91", "doi-asserted-by": "crossref", "first-page": "G63", "DOI": "10.1152/ajpgi.00565.2005", "article-title": "Hepatic cytochrome P-450 reductase-null mice show reduced transcriptional response to quercetin and reveal physiological homeostasis between jejunum and liver", "volume": "291", "author": "Mutch", "year": "2006", "journal-title": "Am J Physiol Gastrointest Liver Physiol"}, {"key": "10.1002/9781118180778.ch28-BIB92|cit92", "doi-asserted-by": "crossref", "first-page": "23847", "DOI": "10.1074/jbc.R400004200", "article-title": "Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer", "volume": "279", "author": "Nebert", "year": "2004", "journal-title": "J Biol Chem"}, {"key": "10.1002/9781118180778.ch28-BIB93|cit93", "doi-asserted-by": "crossref", "first-page": "7901", "DOI": "10.1074/jbc.M709244200", "article-title": "Disruption of the ugt1 locus in mice resembles human Crigler-Najjar type I disease", "volume": "283", "author": "Nguyen", "year": "2008", "journal-title": "J Biol Chem"}, {"key": "10.1002/9781118180778.ch28-BIB94|cit94", "doi-asserted-by": "crossref", "first-page": "17923", "DOI": "10.1073/pnas.0506483102", "article-title": "A human transporter protein that mediates the final excretion step for toxic organic cations", "volume": "102", "author": "Otsuka", "year": "2005", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "10.1002/9781118180778.ch28-BIB95|cit95", "doi-asserted-by": "crossref", "first-page": "6103", "DOI": "10.1128/MCB.23.17.6103-6116.2003", "article-title": "Identification of novel roles of the cytochrome p450 system in early embryogenesis: Effects on vasculogenesis and retinoic Acid homeostasis", "volume": "23", "author": "Otto", "year": "2003", "journal-title": "Mol Cell Biol"}, {"key": "10.1002/9781118180778.ch28-BIB96|cit96", "doi-asserted-by": "crossref", "first-page": "4211", "DOI": "10.1158/0008-5472.CAN-04-4103", "article-title": "Role of hepatic cytochrome p450s in the pharmacokinetics and toxicity of cyclophosphamide: Studies with the hepatic cytochrome p450 reductase null mouse", "volume": "65", "author": "Pass", "year": "2005", "journal-title": "Cancer Res"}, {"key": "10.1002/9781118180778.ch28-BIB97|cit97", "doi-asserted-by": "crossref", "first-page": "5134", "DOI": "10.1073/pnas.92.11.5134", "article-title": "Neonatal lethality associated with respiratory distress in mice lacking cytochrome P450 1A2", "volume": "92", "author": "Pineau", "year": "1995", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "10.1002/9781118180778.ch28-BIB98|cit98", "doi-asserted-by": "crossref", "first-page": "5342", "DOI": "10.1210/en.142.12.5342", "article-title": "Targeted disruption of the mouse estrogen sulfotransferase gene reveals a role of estrogen metabolism in intracrine and paracrine estrogen regulation", "volume": "142", "author": "Qian", "year": "2001", "journal-title": "Endocrinology"}, {"key": "10.1002/9781118180778.ch28-BIB99|cit99", "doi-asserted-by": "crossref", "first-page": "3891", "DOI": "10.1073/pnas.0712328105", "article-title": "The organic solute transporter alpha-beta, Ostalpha-Ostbeta, is essential for intestinal bile acid transport and homeostasis", "volume": "105", "author": "Rao", "year": "2008", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "10.1002/9781118180778.ch28-BIB100|cit100", "doi-asserted-by": "crossref", "first-page": "3", "DOI": "10.1016/j.addr.2008.11.003", "article-title": "ABCG2: A perspective", "volume": "61", "author": "Robey", "year": "2009", "journal-title": "Adv Drug Deliv Rev"}, {"key": "10.1002/9781118180778.ch28-BIB101|cit101", "doi-asserted-by": "crossref", "first-page": "1737", "DOI": "10.2217/14622416.9.11.1737", "article-title": "CYP2A6 polymorphisms and risk for tobacco-related cancers", "volume": "9", "author": "Rossini", "year": "2008", "journal-title": "Pharmacogenomics"}, {"key": "10.1002/9781118180778.ch28-BIB102|cit102", "doi-asserted-by": "crossref", "first-page": "3247", "DOI": "10.1128/MCB.23.9.3247-3252.2003", "article-title": "Targeted disruption of the peptide transporter Pept2 gene in mice defines its physiological role in the kidney", "volume": "23", "author": "Rubio-Aliaga", "year": "2003", "journal-title": "Mol Cell Biol"}, {"key": "10.1002/9781118180778.ch28-BIB103|cit103", "doi-asserted-by": "crossref", "first-page": "292", "DOI": "10.1124/mol.65.2.292", "article-title": "A novel constitutive androstane receptor-mediated and CYP3A-independent pathway of bile acid detoxification", "volume": "65", "author": "Saini", "year": "2004", "journal-title": "Mol Pharmacol"}, {"key": "10.1002/9781118180778.ch28-BIB104|cit104", "doi-asserted-by": "crossref", "first-page": "491", "DOI": "10.1016/0092-8674(94)90212-7", "article-title": "Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs", "volume": "77", "author": "Schinkel", "year": "1994", "journal-title": "Cell"}, {"key": "10.1002/9781118180778.ch28-BIB105|cit105", "doi-asserted-by": "crossref", "first-page": "1698", "DOI": "10.1172/JCI118214", "article-title": "Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A", "volume": "96", "author": "Schinkel", "year": "1995", "journal-title": "J Clin Invest"}, {"key": "10.1002/9781118180778.ch28-BIB106|cit106", "doi-asserted-by": "crossref", "first-page": "2517", "DOI": "10.1172/JCI118699", "article-title": "P-glycoprotein in the blood-brain barrier of mice infl uences the brain penetration and pharmacological activity of many drugs", "volume": "97", "author": "Schinkel", "year": "1996", "journal-title": "J Clin Invest"}, {"key": "10.1002/9781118180778.ch28-BIB107|cit107", "doi-asserted-by": "crossref", "first-page": "4028", "DOI": "10.1073/pnas.94.8.4028", "article-title": "Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins", "volume": "94", "author": "Schinkel", "year": "1997", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "10.1002/9781118180778.ch28-BIB108|cit108", "doi-asserted-by": "crossref", "first-page": "6731", "DOI": "10.1073/pnas.93.13.6731", "article-title": "Characterization of a murine Ahr null allele: Involvement of the Ah receptor in hepatic growth and development", "volume": "93", "author": "Schmidt", "year": "1996", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "10.1002/9781118180778.ch28-BIB109|cit109", "doi-asserted-by": "crossref", "first-page": "419", "DOI": "10.1124/dmd.106.013243", "article-title": "Expression of the human UGT1 locus in transgenic mice by 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid (WY-14643) and implications on drug metabolism through peroxisome proliferator-activated receptor alpha activation", "volume": "35", "author": "Senekeo-Effenberger", "year": "2007", "journal-title": "Drug Metab Dispos"}, {"key": "10.1002/9781118180778.ch28-BIB110|cit110", "doi-asserted-by": "crossref", "first-page": "6536", "DOI": "10.1074/jbc.M111408200", "article-title": "Association of multiple developmental defects and embryonic lethality with loss of microsomal NADPH-cytochrome P450 oxidoreductase", "volume": "277", "author": "Shen", "year": "2002", "journal-title": "J Biol Chem"}, {"key": "10.1002/9781118180778.ch28-BIB111|cit111", "doi-asserted-by": "crossref", "first-page": "4786", "DOI": "10.1074/jbc.M207397200", "article-title": "Targeted disruption of the PEPT2 gene markedly reduces dipeptide uptake in choroid plexus", "volume": "278", "author": "Shen", "year": "2003", "journal-title": "J Biol Chem"}, {"key": "10.1002/9781118180778.ch28-BIB112|cit112", "doi-asserted-by": "crossref", "first-page": "1209", "DOI": "10.1124/dmd.107.015263", "article-title": "Impact of genetic knockout of PEPT2 on cefadroxil pharmacokinetics, renal tubular reabsorption, and brain penetration in mice", "volume": "35", "author": "Shen", "year": "2007", "journal-title": "Drug Metab Dispos"}, {"key": "10.1002/9781118180778.ch28-BIB113|cit113", "doi-asserted-by": "crossref", "first-page": "234", "DOI": "10.2174/187231209790218118", "article-title": "Difference in desipramine metabolic profile between wild-type and CYP2D6-humanized mice", "volume": "3", "author": "Shen", "year": "2009", "journal-title": "Drug Metab Lett"}, {"key": "10.1002/9781118180778.ch28-BIB114|cit114", "doi-asserted-by": "crossref", "first-page": "281", "DOI": "10.1038/nrurol.2009.49", "article-title": "Glutathione S-transferases in kidney and urinary bladder tumors", "volume": "6", "author": "Simic", "year": "2009", "journal-title": "Nat Rev Urol"}, {"key": "10.1002/9781118180778.ch28-BIB115|cit115", "doi-asserted-by": "crossref", "first-page": "677", "DOI": "10.1038/clpt.1984.239", "article-title": "Phenotypic consistency in hydroxylation of desmethylimipramine and debrisoquine in healthy subjects and in human liver microsomes", "volume": "36", "author": "Spina", "year": "1984", "journal-title": "Clin Pharmacol Ther"}, {"key": "10.1002/9781118180778.ch28-BIB116|cit116", "doi-asserted-by": "crossref", "first-page": "3369", "DOI": "10.1073/pnas.051551698", "article-title": "The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity", "volume": "98", "author": "Staudinger", "year": "2001", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "10.1002/9781118180778.ch28-BIB117|cit117", "doi-asserted-by": "crossref", "first-page": "277", "DOI": "10.1124/dmd.108.024315", "article-title": "Methotrexate pharmacokinetics in transgenic mice with liver-specific expression of human organic anion-transporting polypeptide 1B1 (SLCO1B1)", "volume": "37", "author": "van de Steeg", "year": "2009", "journal-title": "Drug Metab Dispos"}, {"key": "10.1002/9781118180778.ch28-BIB118|cit118", "doi-asserted-by": "crossref", "first-page": "611", "DOI": "10.1007/s00424-006-0152-8", "article-title": "The bile salt export pump", "volume": "453", "author": "Stieger", "year": "2007", "journal-title": "Pfl ugers Arch"}, {"key": "10.1002/9781118180778.ch28-BIB119|cit119", "doi-asserted-by": "crossref", "first-page": "285", "DOI": "10.1016/j.taap.2003.11.029", "article-title": "Regulation of the cytochrome P450 2A genes", "volume": "199", "author": "Su", "year": "2004", "journal-title": "Toxicol Appl Pharmacol"}, {"key": "10.1002/9781118180778.ch28-BIB120|cit120", "doi-asserted-by": "crossref", "first-page": "1007", "DOI": "10.1101/gad.8.9.1007", "article-title": "RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis", "volume": "8", "author": "Sucov", "year": "1994", "journal-title": "Genes Dev"}, {"key": "10.1002/9781118180778.ch28-BIB121|cit121", "doi-asserted-by": "crossref", "first-page": "26934", "DOI": "10.1074/jbc.M203803200", "article-title": "Impaired organic anion transport in kidney and choroid plexus of organic anion transporter 3 (Oat3 [Slc22a8]) knockout mice", "volume": "277", "author": "Sweet", "year": "2002", "journal-title": "J Biol Chem"}, {"key": "10.1002/9781118180778.ch28-BIB122|cit122", "doi-asserted-by": "crossref", "first-page": "F972", "DOI": "10.1152/ajprenal.00356.2003", "article-title": "Organic anion transport in choroid plexus from wild-type and organic anion transporter 3 (Slc22a8)-null mice", "volume": "286", "author": "Sykes", "year": "2004", "journal-title": "Am J Physiol Renal Physiol"}, {"key": "10.1002/9781118180778.ch28-BIB123|cit123", "doi-asserted-by": "crossref", "first-page": "6965", "DOI": "10.1158/0008-5472.CAN-06-4720", "article-title": "Substrate overlap between Mrp4 and Abcg2/Bcrp affects purine analogue drug cytotoxicity and tissue distribution", "volume": "67", "author": "Takenaka", "year": "2007", "journal-title": "Cancer Res"}, {"key": "10.1002/9781118180778.ch28-BIB124|cit124", "doi-asserted-by": "crossref", "first-page": "231", "DOI": "10.1016/j.steroids.2006.12.006", "article-title": "CAR and PXR: The xenobiotic-sensing receptors", "volume": "72", "author": "Timsit", "year": "2007", "journal-title": "Steroids"}, {"key": "10.1002/9781118180778.ch28-BIB125|cit125", "doi-asserted-by": "crossref", "first-page": "1169", "DOI": "10.1002/jps.20324", "article-title": "Nuclear receptors and drug disposition gene regulation", "volume": "94", "author": "Tirona", "year": "2005", "journal-title": "J Pharm Sci"}, {"key": "10.1002/9781118180778.ch28-BIB126|cit126", "doi-asserted-by": "crossref", "first-page": "153", "DOI": "10.1038/nm1184", "article-title": "Spontaneous fetal loss caused by placental thrombosis in estrogen sulfotransferase-deficient mice", "volume": "11", "author": "Tong", "year": "2005", "journal-title": "Nat Med"}, {"key": "10.1002/9781118180778.ch28-BIB127|cit127", "doi-asserted-by": "crossref", "first-page": "1280", "DOI": "10.1124/mol.109.056242", "article-title": "Targeted disruption of the multidrug and toxin extrusion 1 (mate1) gene in mice reduces renal secretion of metformin", "volume": "75", "author": "Tsuda", "year": "2009", "journal-title": "Mol Pharmacol"}, {"key": "10.1002/9781118180778.ch28-BIB128|cit128", "doi-asserted-by": "crossref", "first-page": "461", "DOI": "10.1016/S0009-9236(99)70009-3", "article-title": "Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: Effect of ketoconazole", "volume": "66", "author": "Tsunoda", "year": "1999", "journal-title": "Clin Pharmacol Ther"}, {"key": "10.1002/9781118180778.ch28-BIB129|cit129", "doi-asserted-by": "crossref", "first-page": "410", "DOI": "10.1016/j.taap.2004.01.014", "article-title": "Cyp1a1(-/-) male mice: Protection against high-dose TCDD-induced lethality and wasting syndrome, and resistance to intrahepatocyte lipid accumulation and uroporphyria", "volume": "196", "author": "Uno", "year": "2004", "journal-title": "Toxicol Appl Pharmacol"}, {"key": "10.1002/9781118180778.ch28-BIB130|cit130", "doi-asserted-by": "crossref", "first-page": "1103", "DOI": "10.1124/mol.105.021501", "article-title": "Oral benzo[a]pyrene in Cyp1 knockout mouse lines: CYP1A1 important in detoxication, CYP1B1 metabolism required for immune damage independent of total-body burden and clearance rate", "volume": "69", "author": "Uno", "year": "2006", "journal-title": "Mol Pharmacol"}, {"key": "10.1002/9781118180778.ch28-BIB131|cit131", "doi-asserted-by": "crossref", "first-page": "319", "DOI": "10.1124/jpet.106.101774", "article-title": "Carcinogen and anticancer drug transport by Mrp2 in vivo: Studies using Mrp2 (Abcc2) knockout mice", "volume": "318", "author": "Vlaming", "year": "2006", "journal-title": "J Pharmacol Exp Ther"}, {"key": "10.1002/9781118180778.ch28-BIB132|cit132", "doi-asserted-by": "crossref", "first-page": "4436", "DOI": "10.1128/MCB.20.12.4436-4444.2000", "article-title": "Hepatocyte-specific mutation establishes retinoid X receptor alpha as a heterodimeric integrator of multiple physiological processes in the liver", "volume": "20", "author": "Wan", "year": "2000", "journal-title": "Mol Cell Biol"}, {"key": "10.1002/9781118180778.ch28-BIB133|cit133", "doi-asserted-by": "crossref", "first-page": "2011", "DOI": "10.1073/pnas.031465498", "article-title": "Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis", "volume": "98", "author": "Wang", "year": "2001", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "10.1002/9781118180778.ch28-BIB134|cit134", "doi-asserted-by": "crossref", "first-page": "1489", "DOI": "10.1016/j.hep.2003.09.037", "article-title": "Severe cholestasis induced by cholic acid feeding in knockout mice of sister of P-glycoprotein", "volume": "38", "author": "Wang", "year": "2003", "journal-title": "Hepatology"}, {"key": "10.1002/9781118180778.ch28-BIB135|cit135", "doi-asserted-by": "crossref", "first-page": "1029", "DOI": "10.1124/mol.107.043869", "article-title": "Midazolam metabolism in cytochrome P450 3A knockout mice can be attributed to up-regulated CYP2C enzymes", "volume": "73", "author": "van Waterschoot", "year": "2008", "journal-title": "Mol Pharmacol"}, {"key": "10.1002/9781118180778.ch28-BIB136|cit136", "doi-asserted-by": "crossref", "first-page": "2305", "DOI": "10.1124/dmd.109.029397", "article-title": "Inhibition and stimulation of intestinal and hepatic CYP3A activity: Studies in humanized CYP3A4 transgenic mice using triazolam", "volume": "37", "author": "van Waterschoot", "year": "2009", "journal-title": "Drug Metab Dispos"}, {"key": "10.1002/9781118180778.ch28-BIB137|cit137", "doi-asserted-by": "crossref", "first-page": "920", "DOI": "10.1038/35038112", "article-title": "The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism", "volume": "407", "author": "Wei", "year": "2000", "journal-title": "Nature"}, {"key": "10.1002/9781118180778.ch28-BIB138|cit138", "doi-asserted-by": "crossref", "first-page": "7825", "DOI": "10.1158/0008-5472.CAN-07-1006", "article-title": "Determination of the role of target tissue metabolism in lung carcinogenesis using conditional cytochrome P450 reductase-null mice", "volume": "67", "author": "Weng", "year": "2007", "journal-title": "Cancer Res"}, {"key": "10.1002/9781118180778.ch28-BIB139|cit139", "doi-asserted-by": "crossref", "first-page": "1275", "DOI": "10.1038/nm1197-1275", "article-title": "Increased sensitivity to anticancer drugs and decreased infl ammatory response in mice lacking the multidrug resistance-associated protein", "volume": "3", "author": "Wijnholds", "year": "1997", "journal-title": "Nat Med"}, {"key": "10.1002/9781118180778.ch28-BIB140|cit140", "doi-asserted-by": "crossref", "first-page": "61", "DOI": "10.1021/tx0497696", "article-title": "Cytochrome P450 2A-catalyzed metabolic activation of structurally similar carcinogenic nitrosamines: N\u2032- nitrosonornicotine enantiomers, N-nitrosopiperidine, and N-nitrosopyrrolidine", "volume": "18", "author": "Wong", "year": "2005", "journal-title": "Chem Res Toxicol"}, {"key": "10.1002/9781118180778.ch28-BIB141|cit141", "doi-asserted-by": "crossref", "first-page": "617", "DOI": "10.1016/j.bcp.2009.05.011", "article-title": "Effects of CYP2D6 status on harmaline metabolism, pharmacokinetics and pharmacodynamics, and a pharmacogenetics-based pharmacokinetic model", "volume": "78", "author": "Wu", "year": "2009", "journal-title": "Biochem Pharmacol"}, {"key": "10.1002/9781118180778.ch28-BIB142|cit142", "doi-asserted-by": "crossref", "first-page": "177", "DOI": "10.1002/gene.10214", "article-title": "Conditional knockout of the mouse NADPH-cytochrome p450 reductase gene", "volume": "36", "author": "Wu", "year": "2003", "journal-title": "Genesis"}, {"key": "10.1002/9781118180778.ch28-BIB143|cit143", "doi-asserted-by": "crossref", "first-page": "35", "DOI": "10.1124/jpet.104.073353", "article-title": "Transgenic mice with a hypomorphic NADPH-cytochrome P450 reductase gene: Effects on development, reproduction, and microsomal cytochrome P450", "volume": "312", "author": "Wu", "year": "2005", "journal-title": "J Pharmacol Exp Ther"}, {"key": "10.1002/9781118180778.ch28-BIB144|cit144", "doi-asserted-by": "crossref", "first-page": "550", "DOI": "10.1124/mol.65.3.550", "article-title": "Retinoid X receptor alpha regulates glutathione homeostasis and xenobiotic detoxification processes in mouse liver", "volume": "65", "author": "Wu", "year": "2004", "journal-title": "Mol Pharmacol"}, {"key": "10.1002/9781118180778.ch28-BIB145|cit145", "doi-asserted-by": "crossref", "first-page": "341", "DOI": "10.2174/138920007780655423", "article-title": "Evaluation of drug-transporter interactions using in vitro and in vivo models", "volume": "8", "author": "Xia", "year": "2007", "journal-title": "Curr Drug Metab"}, {"key": "10.1002/9781118180778.ch28-BIB146|cit146", "doi-asserted-by": "crossref", "first-page": "435", "DOI": "10.1038/35019116", "article-title": "Humanized xenobiotic response in mice expressing nuclear receptor SXR", "volume": "406", "author": "Xie", "year": "2000", "journal-title": "Nature"}, {"key": "10.1002/9781118180778.ch28-BIB147|cit147", "doi-asserted-by": "crossref", "first-page": "242", "DOI": "10.1208/s12248-008-9028-5", "article-title": "Indolealkylamines: Biotransformations and potential drug-drug interactions", "volume": "10", "author": "Yu", "year": "2008", "journal-title": "AAPS J"}, {"key": "10.1002/9781118180778.ch28-BIB148|cit148", "doi-asserted-by": "crossref", "first-page": "173", "DOI": "10.1097/00008571-200303000-00007", "article-title": "Regeneration of serotonin from 5-methoxytryptamine by polymorphic human CYP2D6", "volume": "13", "author": "Yu", "year": "2003a", "journal-title": "Pharmacogenetics"}, {"key": "10.1002/9781118180778.ch28-BIB149|cit149", "doi-asserted-by": "crossref", "first-page": "307", "DOI": "10.1097/00008571-200306000-00002", "article-title": "Screening for endogenous substrates reveals that CYP2D6 is a 5-methoxyindolethylamine O-demethylase", "volume": "13", "author": "Yu", "year": "2003b", "journal-title": "Pharmacogenetics"}, {"key": "10.1002/9781118180778.ch28-BIB150|cit150", "doi-asserted-by": "crossref", "first-page": "315", "DOI": "10.1124/jpet.102.047050", "article-title": "Contribution of individual cytochrome P450 isozymes to the O-demethylation of the psychotropic beta-carboline alkaloids harmaline and harmine", "volume": "305", "author": "Yu", "year": "2003c", "journal-title": "J Pharmacol Exp Ther"}, {"key": "10.1002/9781118180778.ch28-BIB151|cit151", "doi-asserted-by": "crossref", "first-page": "2911", "DOI": "10.1210/en.2004-1248", "article-title": "Potential role for human cytochrome P450 3A4 in estradiol homeostasis", "volume": "146", "author": "Yu", "year": "2005", "journal-title": "Endocrinology"}, {"key": "10.1002/9781118180778.ch28-BIB152|cit152", "doi-asserted-by": "crossref", "first-page": "320", "DOI": "10.1124/mol.108.046458", "article-title": "Targeted disruption of murine organic anion-transporting polypeptide 1b2 (Oatp1b2/Slco1b2) signifi-cantly alters disposition of prototypical drug substrates pravastatin and rifampin", "volume": "74", "author": "Zaher", "year": "2008", "journal-title": "Mol Pharmacol"}, {"key": "10.1002/9781118180778.ch28-BIB153|cit153", "doi-asserted-by": "crossref", "first-page": "597", "DOI": "10.2217/14622416.9.5.597", "article-title": "Pharmacogenetics of OATP (SLC21/SLCO), OAT and OCT (SLC22) and PEPT (SLC15) transporters in the intestine, liver and kidney", "volume": "9", "author": "Zair", "year": "2008", "journal-title": "Pharmacogenomics"}, {"key": "10.1002/9781118180778.ch28-BIB154|cit154", "doi-asserted-by": "crossref", "first-page": "23", "DOI": "10.1007/s00210-003-0832-2", "article-title": "Cytochrome P450 2D6: Overview and update on pharmacology, genetics, biochemistry", "volume": "369", "author": "Zanger", "year": "2004", "journal-title": "Naunyn Schmiedebergs Arch Pharmacol"}, {"key": "10.1002/9781118180778.ch28-BIB155|cit155", "doi-asserted-by": "crossref", "first-page": "7274", "DOI": "10.1073/pnas.0502530102", "article-title": "Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception", "volume": "102", "author": "Zelcer", "year": "2005", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "10.1002/9781118180778.ch28-BIB156|cit156", "doi-asserted-by": "crossref", "first-page": "768", "DOI": "10.1016/j.jhep.2005.07.022", "article-title": "Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronides", "volume": "44", "author": "Zelcer", "year": "2006", "journal-title": "J Hepatol"}, {"key": "10.1002/9781118180778.ch28-BIB157|cit157", "doi-asserted-by": "crossref", "first-page": "422", "DOI": "10.1126/science.1073502", "article-title": "Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR", "volume": "298", "author": "Zhang", "year": "2002", "journal-title": "Science"}, {"key": "10.1002/9781118180778.ch28-BIB158|cit158", "doi-asserted-by": "crossref", "first-page": "318", "DOI": "10.1016/j.bbrc.2005.08.086", "article-title": "Generation and characterization of a transgenic mouse model with hepatic expression of human CYP2A6", "volume": "338", "author": "Zhang", "year": "2005", "journal-title": "Biochem Biophys Res Commun"}, {"key": "10.1002/9781118180778.ch28-BIB159|cit159", "doi-asserted-by": "crossref", "first-page": "651", "DOI": "10.1124/dmd.108.025429", "article-title": "An intestinal epithelium-specific cytochrome P450 (P450) reductase-knockout mouse model: Direct evidence for a role of intestinal p450s in first-pass clearance of oral nifedipine", "volume": "37", "author": "Zhang", "year": "2009", "journal-title": "Drug Metab Dispos"}, {"key": "10.1002/9781118180778.ch28-BIB160|cit160", "doi-asserted-by": "crossref", "first-page": "12339", "DOI": "10.1073/pnas.192276999", "article-title": "Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo", "volume": "99", "author": "Zhou", "year": "2002", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "10.1002/9781118180778.ch28-BIB161|cit161", "doi-asserted-by": "crossref", "first-page": "802", "DOI": "10.1080/00498250701867889", "article-title": "Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition", "volume": "38", "author": "Zhou", "year": "2008", "journal-title": "Xenobiotica"}, {"key": "10.1002/9781118180778.ch28-BIB162|cit162", "doi-asserted-by": "crossref", "first-page": "578", "DOI": "10.1124/jpet.109.162610", "article-title": "Role of CYP2A5 in the clearance of nicotine and cotinine: Insights from studies on a Cyp2a5-null mouse model", "volume": "332", "author": "Zhou", "year": "2009", "journal-title": "J Pharmacol Exp Ther"}, {"key": "10.1002/9781118180778.ch28-BIB163|cit163", "doi-asserted-by": "crossref", "first-page": "4188", "DOI": "10.1128/MCB.21.13.4188-4196.2001", "article-title": "Impaired activity of the extraneuronal monoamine transporter system known as uptake-2 in Orct3/Slc22a3-deficient mice", "volume": "21", "author": "Zwart", "year": "2001", "journal-title": "Mol Cell Biol"}], "container-title": ["ADME-Enabling Technologies in Drug Design and Development"], "deposited": {"date-parts": [[2019, 6, 28]], "date-time": "2019-06-28T19:48:03Z", "timestamp": 1561751283000}, "score": 33.25218, "issued": {"date-parts": [[2012, 5, 15]]}, "ISBN": ["9781118180778", "9780470542781"], "references-count": 163, "URL": "http://dx.doi.org/10.1002/9781118180778.ch28", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T02:33:23Z", "timestamp": 1574476403013}, "publisher-location": "Hoboken, NJ, USA", "reference-count": 57, "publisher": "John Wiley & Sons, Inc.", "isbn-type": [{"value": "9780470542781", "type": "print"}, {"value": "9781118180778", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1002/9781118180778.ch7", "type": "book-chapter", "created": {"date-parts": [[2012, 5, 16]], "date-time": "2012-05-16T03:06:24Z", "timestamp": 1337137584000}, "page": "95-107", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Pharmacogenomics and Individualized Medicine"], "prefix": "10.1002", "author": [{"given": "Anthony Y. H.", "family": "Lu", "sequence": "first", "affiliation": []}, {"given": "Qiang", "family": "Ma", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2012, 5, 15]]}, "reference": [{"key": "10.1002/9781118180778.ch7-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "355", "DOI": "10.1080/03602530801952187", "article-title": "Pharmacogenomics of 4-hydroxycoumarin anticoagulants", "volume": "40", "author": "Au", "year": "2008", "journal-title": "Drug Metab Rev"}, {"key": "10.1002/9781118180778.ch7-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "1533", "DOI": "10.1111/j.1538-7836.2005.01449.x", "article-title": "A vitamin K epoxide reductase complex subunit-1 (VKORC1) mutation in a patient with vitamin K antagonist resistance", "volume": "3", "author": "Bodin", "year": "2005", "journal-title": "J Thromb Haemost"}, {"key": "10.1002/9781118180778.ch7-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.1592/phco.28.2.141", "article-title": "Editorial: Genetic testing for warfarin dosing? Not yet ready for prime time", "volume": "28", "author": "Bussey", "year": "2008", "journal-title": "Pharmacotherapy"}, {"key": "10.1002/9781118180778.ch7-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "2821", "DOI": "10.1001/jama.291.23.2821", "article-title": "Pharmacogenetic study of statin therapy and cholesterol reduction", "volume": "291", "author": "Chasman", "year": "2004", "journal-title": "JAMA"}, {"key": "10.1002/9781118180778.ch7-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "38", "DOI": "10.1016/S0002-9149(96)00742-4", "article-title": "The efficacy and six-week tolerability of simvastatin 80 and 160 mg/day", "volume": "79", "author": "Davidson", "year": "1997", "journal-title": "Am J Cardiol"}, {"key": "10.1002/9781118180778.ch7-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "3", "DOI": "10.1172/JCI9083", "article-title": "Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia", "volume": "105", "author": "Druker", "year": "2000", "journal-title": "J Clin Invest"}, {"key": "10.1002/9781118180778.ch7-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.1146/annurev.med.56.082103.104724", "article-title": "Pharmacogenomics and individualized drug therapy", "volume": "57", "author": "Eichelbaum", "year": "2006", "journal-title": "Annu Rev Med"}, {"key": "10.1002/9781118180778.ch7-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "485", "DOI": "10.1136/bmj.2.5197.485", "article-title": "Genetic control of isoniazid metabolism in man", "volume": "2", "author": "Evans", "year": "1960", "journal-title": "Br Med J"}, {"key": "10.1002/9781118180778.ch7-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1146/annurev.genom.2.1.9", "article-title": "Pharmacogenomics: The inherited basis for interindividual differences in drug response", "volume": "2", "author": "Evans", "year": "2001", "journal-title": "Annu Rev Genomics Hum Genet"}, {"key": "10.1002/9781118180778.ch7-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "538", "DOI": "10.1056/NEJMra020526", "article-title": "Pharmacogenomics: Drug disposition, drug targets and side effects", "volume": "348", "author": "Evans", "year": "2003", "journal-title": "N Engl J Med"}, {"key": "10.1002/9781118180778.ch7-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "487", "DOI": "10.1126/science.286.5439.487", "article-title": "Pharmacogenomics: Translating functional genomics into rational therapeutics", "volume": "286", "author": "Evans", "year": "1999", "journal-title": "Science"}, {"key": "10.1002/9781118180778.ch7-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "464", "DOI": "10.1038/nature02626", "article-title": "Moving towards individualized medicine with pharmacogenomics", "volume": "429", "author": "Evans", "year": "2004", "journal-title": "Nature"}, {"key": "10.1002/9781118180778.ch7-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "552", "DOI": "10.1016/S0009-9236(99)70075-5", "article-title": "CYP2C19 genotype status and effect of omeprazole on intragastric pH in humans", "volume": "65", "author": "Furuta", "year": "1999", "journal-title": "Clin Pharmacol Ther"}, {"key": "10.1002/9781118180778.ch7-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "45", "DOI": "10.1007/s11239-007-0104-y", "article-title": "Pharmacogenetics of warfarin: Regulatory, scientific and clinical issues", "volume": "25", "author": "Gage", "year": "2008", "journal-title": "J Thromb Thrombolysis"}, {"key": "10.1002/9781118180778.ch7-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "317", "DOI": "10.1080/03602530801952617", "article-title": "Pharmacogenomics of MRP transporters (ABCC1-5) and BCRP (ABCG2)", "volume": "40", "author": "Gradhand", "year": "2008", "journal-title": "Drug Metab Rev"}, {"key": "10.1002/9781118180778.ch7-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1056/NEJMra043186", "article-title": "Trastuzumab: Mechanism of action and use in clinical practice", "volume": "357", "author": "Hudis", "year": "2007", "journal-title": "N Engl J Med"}, {"key": "10.1002/9781118180778.ch7-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "297", "DOI": "10.1002/1098-1004(200010)16:4<297::AID-HUMU2>3.0.CO;2-Z", "article-title": "Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: Correlation of genotype and phenotype", "volume": "16", "author": "Kadakol", "year": "2000", "journal-title": "Hum Mutat"}, {"key": "10.1002/9781118180778.ch7-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "138", "DOI": "10.1177/0091270008328098", "article-title": "A regulatory science perspective on warfarin therapy: A pharmacogenetic opportunity", "volume": "49", "author": "Kim", "year": "2009", "journal-title": "J Clin Pharmacol"}, {"key": "10.1002/9781118180778.ch7-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "383", "DOI": "10.1038/86882", "article-title": "Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression", "volume": "27", "author": "Kuehl", "year": "2001", "journal-title": "Nat Genet"}, {"key": "10.1002/9781118180778.ch7-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "121", "DOI": "10.1097/00008571-200203000-00006", "article-title": "Common allelic variants of cytochrome P4503A4 and their prevalence in different populations", "volume": "12", "author": "Lamba", "year": "2002", "journal-title": "Pharmacogenetics"}, {"key": "10.1002/9781118180778.ch7-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "251", "DOI": "10.1097/00008571-200204000-00010", "article-title": "Cytochrome P450 2C9 polymorphisms: A comprehensive review of the in vitro and human data", "volume": "12", "author": "Lee", "year": "2002", "journal-title": "Pharmacogenetics"}, {"key": "10.1002/9781118180778.ch7-BIB22|cit22", "doi-asserted-by": "crossref", "first-page": "519", "DOI": "10.1016/S0009-9236(99)70071-8", "article-title": "Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics", "volume": "65", "author": "Lima", "year": "1999", "journal-title": "Clin Pharmacol Ther"}, {"key": "10.1002/9781118180778.ch7-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "1084", "DOI": "10.1592/phco.28.9.1084", "article-title": "Warfarin pharmacogenetics", "volume": "28", "author": "Limdi", "year": "2008", "journal-title": "Pharmacotherapy"}, {"key": "10.1002/9781118180778.ch7-BIB24|cit24", "doi-asserted-by": "crossref", "first-page": "109", "DOI": "10.2174/138920007779816002", "article-title": "Pharmacokinetic and pharmacodynamic variability: A daunting challenge in drug therapy", "volume": "8", "author": "Lin", "year": "2007", "journal-title": "Curr Drug Metab"}, {"key": "10.1002/9781118180778.ch7-BIB25|cit25", "doi-asserted-by": "crossref", "first-page": "535", "DOI": "10.1146/annurev.pharmtox.41.1.535", "article-title": "Interindividual variability in inhibition and induction of cytochrome P450 enzymes", "volume": "41", "author": "Lin", "year": "2001", "journal-title": "Annu Rev Pharmacol Toxicol"}, {"key": "10.1002/9781118180778.ch7-BIB26|cit26", "first-page": "1217", "article-title": "Drug-metabolism research challenges in the new millennium: Individual variability in drug therapy and drug safety", "volume": "26", "author": "Lu", "year": "1998", "journal-title": "Drug Metab Dispos"}, {"key": "10.1002/9781118180778.ch7-BIB27|cit27", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.1146/annurev.pharmtox.41.1.101", "article-title": "Pharmacogenomics: Unlocking the human genome for better drug therapy", "volume": "41", "author": "McLeod", "year": "2001", "journal-title": "Annu Rev Pharmacol Toxicol"}, {"key": "10.1002/9781118180778.ch7-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "1667", "DOI": "10.1016/S0140-6736(00)03167-6", "article-title": "Pharmacogenetics and adverse drug reactions", "volume": "356", "author": "Meyer", "year": "2000", "journal-title": "Lancet"}, {"key": "10.1002/9781118180778.ch7-BIB29|cit29", "doi-asserted-by": "crossref", "first-page": "2287", "DOI": "10.1124/dmd.108.021816", "article-title": "Defective activity of recombinant cytochromes P450 3A4.2 and 3A4.16 in oxidation of midazolam, nifedipine and testosterone", "volume": "36", "author": "Miyazaki", "year": "2008", "journal-title": "Drug Metab Dispos"}, {"key": "10.1002/9781118180778.ch7-BIB30|cit30", "doi-asserted-by": "crossref", "first-page": "415", "DOI": "10.1016/j.clpt.2003.12.016", "article-title": "Evidence for inverse effects of OATP-C (SLC21A6) * 5 and * 1b haplotypes on pravastatin kinetics", "volume": "75", "author": "Mwinyi", "year": "2004", "journal-title": "Clin Pharmacol Ther"}, {"key": "10.1002/9781118180778.ch7-BIB31|cit31", "doi-asserted-by": "crossref", "first-page": "580", "DOI": "10.1016/j.tips.2006.09.008", "article-title": "Can personalized drug therapy be achieved? A closer look at pharmaco-metabonomics", "volume": "27", "author": "Nebert", "year": "2006", "journal-title": "Trends Pharmacol Sci"}, {"key": "10.1002/9781118180778.ch7-BIB32|cit32", "doi-asserted-by": "crossref", "first-page": "187", "DOI": "10.1080/03602530801952864", "article-title": "From human genetics and genomics to pharmacogenetics and pharmacogenomics: Past lessons, future directions", "volume": "40", "author": "Nebert", "year": "2008", "journal-title": "Drug Metab Rev"}, {"key": "10.1002/9781118180778.ch7-BIB33|cit33", "doi-asserted-by": "crossref", "first-page": "468", "DOI": "10.1016/j.clpt.2005.01.018", "article-title": "Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics", "volume": "77", "author": "Niemi", "year": "2005", "journal-title": "Clin Pharmacol Ther"}, {"key": "10.1002/9781118180778.ch7-BIB34|cit34", "doi-asserted-by": "crossref", "first-page": "554", "DOI": "10.1016/S0009-9236(03)00060-2", "article-title": "Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: Consequences for pravastatin pharmacokinetics", "volume": "73", "author": "Nishizato", "year": "2003", "journal-title": "Clin Pharmacol Ther"}, {"key": "10.1002/9781118180778.ch7-BIB35|cit35", "doi-asserted-by": "crossref", "first-page": "223", "DOI": "10.1124/mi.6.4.8", "article-title": "The pharmacogenomics of warfarin: Closing in on personalized medicine", "volume": "6", "author": "Rettie", "year": "2006", "journal-title": "Mol Interv"}, {"key": "10.1002/9781118180778.ch7-BIB36|cit36", "doi-asserted-by": "crossref", "first-page": "2285", "DOI": "10.1056/NEJMoa044503", "article-title": "Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose", "volume": "352", "author": "Rieder", "year": "2005", "journal-title": "N Engl J Med"}, {"key": "10.1002/9781118180778.ch7-BIB37|cit37", "doi-asserted-by": "crossref", "first-page": "749", "DOI": "10.7326/0003-4819-145-10-200611210-00007", "article-title": "Pharmacogenomics: Challenges and opportunities", "volume": "145", "author": "Roden", "year": "2006", "journal-title": "Ann Intern Med"}, {"key": "10.1002/9781118180778.ch7-BIB38|cit38", "doi-asserted-by": "crossref", "first-page": "537", "DOI": "10.1038/nature02214", "article-title": "Muta- tions in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2", "volume": "427", "author": "Rost", "year": "2004", "journal-title": "Nature"}, {"key": "10.1002/9781118180778.ch7-BIB39|cit39", "doi-asserted-by": "crossref", "first-page": "928", "DOI": "10.1038/35057149", "article-title": "A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms", "volume": "409", "author": "Sachidanandam", "year": "2001", "journal-title": "Nature"}, {"key": "10.1002/9781118180778.ch7-BIB40|cit40", "doi-asserted-by": "crossref", "first-page": "1400", "DOI": "10.1023/A:1012244520615", "article-title": "MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects", "volume": "18", "author": "Sakaeda", "year": "2001", "journal-title": "Pharm Res"}, {"key": "10.1002/9781118180778.ch7-BIB41|cit41", "doi-asserted-by": "crossref", "first-page": "722", "DOI": "10.1038/382722a0", "article-title": "Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene", "volume": "382", "author": "Samson", "year": "1996", "journal-title": "Nature"}, {"key": "10.1002/9781118180778.ch7-BIB42|cit42", "doi-asserted-by": "crossref", "first-page": "48", "DOI": "10.1067/mcp.2000.104391", "article-title": "CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: Evidence for an allelic variant with altered catalytic activity", "volume": "67", "author": "Sata", "year": "2000", "journal-title": "Clin Pharmacol Ther"}, {"key": "10.1002/9781118180778.ch7-BIB43|cit43", "doi-asserted-by": "crossref", "first-page": "201", "DOI": "10.1016/j.clpt.2004.05.002", "article-title": "CYP2C19 polymorphism is a major predictor of treatment failure in white patients by use of lansoprazole-based quadruple therapy for eradication of Helicobacter pylori", "volume": "76", "author": "Schwab", "year": "2004", "journal-title": "Clin Pharmacol Ther"}, {"key": "10.1002/9781118180778.ch7-BIB44|cit44", "doi-asserted-by": "crossref", "first-page": "959", "DOI": "10.1126/science.277.5328.959", "article-title": "Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression", "volume": "382", "author": "Smith", "year": "1997", "journal-title": "Science"}, {"key": "10.1002/9781118180778.ch7-BIB45|cit45", "doi-asserted-by": "crossref", "first-page": "1163", "DOI": "10.1126/science.1101637", "article-title": "Gefitinib-sensitizing EGFR mutations in lung cancer activate antiapoptotic pathways", "volume": "305", "author": "Sordella", "year": "2004", "journal-title": "Science"}, {"key": "10.1002/9781118180778.ch7-BIB46|cit46", "doi-asserted-by": "crossref", "first-page": "38", "DOI": "10.1016/j.clpt.2004.03.003", "article-title": "Diflomotecan pharmacokinetics in relation to ABCG2 421C> A genotype", "volume": "76", "author": "Sparreboom", "year": "2004", "journal-title": "Clin Pharmacol Ther"}, {"key": "10.1002/9781118180778.ch7-BIB47|cit47", "doi-asserted-by": "crossref", "first-page": "753", "DOI": "10.1056/NEJMoa0809329", "article-title": "Estimation of the warfarin dose with clinical and pharmacogenetic data", "volume": "360", "author": "The International Warfarin Pharmacogenetics Consortium", "year": "2009", "journal-title": "N Engl J Med"}, {"key": "10.1002/9781118180778.ch7-BIB48|cit48", "doi-asserted-by": "crossref", "first-page": "789", "DOI": "10.1056/NEJMoa0801936", "article-title": "SLCO1B1 variants and statin-induced myopathy: A genomewide study", "volume": "359", "author": "The SEARCH Collaborative Group", "year": "2008", "journal-title": "N Engl J Med"}, {"key": "10.1002/9781118180778.ch7-BIB49|cit49", "doi-asserted-by": "crossref", "first-page": "35669", "DOI": "10.1074/jbc.M103792200", "article-title": "Polymorphisms in OATP-C: Identification of multiple allelic variants associated with altered transport activity among European-and African-Americans", "volume": "276", "author": "Tirona", "year": "2001", "journal-title": "J Biol Chem"}, {"key": "10.1002/9781118180778.ch7-BIB50|cit50", "doi-asserted-by": "crossref", "first-page": "581", "DOI": "10.1146/annurev.pharmtox.40.1.581", "article-title": "Human UDP-glucuronosyltransferases: Metabolism, expression and disease", "volume": "40", "author": "Tukey", "year": "2000", "journal-title": "Annu Rev Pharmacol Toxicol"}, {"key": "10.1002/9781118180778.ch7-BIB51|cit51", "doi-asserted-by": "crossref", "first-page": "446", "DOI": "10.1124/mol.62.3.446", "article-title": "Pharmacogenomics of human UDP-glucuronosyltransferases and irinotecan toxicity", "volume": "62", "author": "Tukey", "year": "2002", "journal-title": "Mol Pharmacol"}, {"key": "10.1002/9781118180778.ch7-BIB52|cit52", "doi-asserted-by": "crossref", "first-page": "809", "DOI": "10.1007/s00228-003-0567-5", "article-title": "Digoxin pharmacokinetics and MDR1 genetic polymorphisms", "volume": "58", "author": "Verstuyft", "year": "2003", "journal-title": "Eur J Clin Pharmacol"}, {"key": "10.1002/9781118180778.ch7-BIB53|cit53", "author": "Weber", "year": "1987", "volume-title": "The Acetylator Genes and Drug Response"}, {"key": "10.1002/9781118180778.ch7-BIB54|cit54", "doi-asserted-by": "crossref", "first-page": "529", "DOI": "10.1056/NEJMra020021", "article-title": "Inheritance and drug response", "volume": "348", "author": "Weinshilboum", "year": "2003a", "journal-title": "N Engl J Med"}, {"key": "10.1002/9781118180778.ch7-BIB55|cit55", "doi-asserted-by": "crossref", "first-page": "118", "DOI": "10.1124/mi.3.3.118", "article-title": "Pharmacogenetics: The future is here", "volume": "3", "author": "Weinshilboum", "year": "2003b", "journal-title": "Mol Interv"}, {"key": "10.1002/9781118180778.ch7-BIB56|cit56", "doi-asserted-by": "crossref", "first-page": "2270", "DOI": "10.1124/dmd.107.017806", "article-title": "Characterization of the UDP glucuronosyltransferase activity of human liver microsomes genotyped for the UGT1A1 * 28 polymorphism", "volume": "35", "author": "Zhang", "year": "2007", "journal-title": "Drug Metab Dispos"}, {"key": "10.1002/9781118180778.ch7-BIB57|cit57", "doi-asserted-by": "crossref", "first-page": "738", "DOI": "10.2174/138920008786049302", "article-title": "Clinical pharmacogenetics and potential application in personalized medicine", "volume": "9", "author": "Zhou", "year": "2008", "journal-title": "Curr Drug Metab"}], "container-title": ["ADME-Enabling Technologies in Drug Design and Development"], "deposited": {"date-parts": [[2017, 6, 20]], "date-time": "2017-06-20T18:48:43Z", "timestamp": 1497984523000}, "score": 32.565323, "issued": {"date-parts": [[2012, 5, 15]]}, "ISBN": ["9781118180778", "9780470542781"], "references-count": 57, "URL": "http://dx.doi.org/10.1002/9781118180778.ch7", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T06:38:09Z", "timestamp": 1574231889065}, "reference-count": 20, "publisher": "Informa Healthcare", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Expert Opinion on Drug Metabolism & Toxicology"], "published-print": {"date-parts": [[2006, 10]]}, "DOI": "10.1517/17425255.2.5.805", "type": "journal-article", "created": {"date-parts": [[2006, 10, 3]], "date-time": "2006-10-03T09:40:48Z", "timestamp": 1159868448000}, "page": "805-817", "source": "Crossref", "is-referenced-by-count": 6, "title": ["A hierarchical screening methodology for physicochemical/ADME/Tox profiling"], "prefix": "10.1517", "volume": "2", "author": [{"given": "Robert S", "family": "DeWitte", "sequence": "first", "affiliation": []}, {"given": "Russell H", "family": "Robins", "sequence": "additional", "affiliation": []}], "member": "3197", "published-online": {"date-parts": [[2006, 10, 3]]}, "reference": [{"key": "CIT0001", "DOI": "10.1126/science.1096800", "doi-asserted-by": "publisher"}, {"key": "CIT0002", "DOI": "10.1016/j.ddtec.2004.11.009", "doi-asserted-by": "publisher"}, {"key": "CIT0003", "DOI": "10.1021/ac0491859", "doi-asserted-by": "publisher"}, {"key": "CIT0004", "DOI": "10.1124/dmd.31.5.606", "doi-asserted-by": "publisher"}, {"key": "CIT0005", "DOI": "10.1124/dmd.105.005033", "doi-asserted-by": "publisher"}, {"key": "CIT0006", "unstructured": "LOVAN K: High throughput drug-drug interaction assay: comparison of LeadStream with a semi-automated approach. Society of Biomolecular Screening, Geneva, Switzerland (2005):P0525."}, {"key": "CIT0007", "unstructured": "HAAS H: High throughput metabolic stability assays: comparison of LeadStream with a semi-automated approach. Society of Biomolecular Screening, Geneva, Switzerland (2005):P0527."}, {"key": "CIT0008", "unstructured": "DEWITTE RS: LeadStream performance characteristics over hundreds of compounds across multiple assays. Society of Biomolecular Screening, Geneva, Switzerland (2005):P0524."}, {"key": "CIT0009", "author": "BURDETTE", "year": "2005", "volume-title": "LabAutomation 2005"}, {"key": "CIT0010", "DOI": "10.1021/ac001036c", "doi-asserted-by": "publisher"}, {"key": "CIT0011", "DOI": "10.1021/ac9912247", "doi-asserted-by": "publisher"}, {"key": "CIT0012", "DOI": "10.1111/j.2042-7158.1990.tb05373.x", "doi-asserted-by": "publisher"}, {"key": "CIT0013", "DOI": "10.1021/jm0000822", "doi-asserted-by": "publisher"}, {"key": "CIT0014", "DOI": "10.1124/dmd.31.8.1005", "doi-asserted-by": "publisher"}, {"key": "CIT0015", "DOI": "10.1021/ac0013251", "doi-asserted-by": "publisher"}, {"key": "CIT0016", "DOI": "10.1002/(SICI)1097-0231(19990530)13:10<901::AID-RCM583>3.0.CO;2-5", "doi-asserted-by": "publisher"}, {"key": "CIT0017", "DOI": "10.1002/(SICI)1097-0231(19980314)12:5<217::AID-RCM146>3.0.CO;2-I", "doi-asserted-by": "publisher"}, {"key": "CIT0018", "DOI": "10.1002/jps.1134", "doi-asserted-by": "publisher"}, {"key": "CIT0019", "DOI": "10.1016/j.jpba.2003.08.001", "doi-asserted-by": "publisher"}, {"key": "CIT0020", "author": "ROBINS", "year": "2005", "volume-title": "Drug Discovery Technology 2005"}], "container-title": ["Expert Opinion on Drug Metabolism & Toxicology"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.1517/17425255.2.5.805", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 13]], "date-time": "2016-12-13T13:46:58Z", "timestamp": 1481636818000}, "score": 30.740425, "issued": {"date-parts": [[2006, 10]]}, "references-count": 20, "journal-issue": {"published-online": {"date-parts": [[2006, 10, 3]]}, "published-print": {"date-parts": [[2006, 10]]}, "issue": "5"}, "alternative-id": ["10.1517/17425255.2.5.805"], "URL": "http://dx.doi.org/10.1517/17425255.2.5.805", "relation": {"cites": []}, "ISSN": ["1742-5255", "1744-7607"], "issn-type": [{"value": "1742-5255", "type": "print"}, {"value": "1744-7607", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T16:58:25Z", "timestamp": 1574096305908}, "reference-count": 16, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2002, 1, 1]], "date-time": "2002-01-01T00:00:00Z", "timestamp": 1009843200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drug Discovery Today"], "published-print": {"date-parts": [[2002, 1]]}, "DOI": "10.1016/s1359-6446(01)02100-6", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T13:43:49Z", "timestamp": 1027604629000}, "page": "109-116", "source": "Crossref", "is-referenced-by-count": 121, "title": ["The emerging importance of predictive ADME simulation in drug discovery"], "prefix": "10.1016", "volume": "7", "author": [{"given": "Harold E", "family": "Selick", "sequence": "first", "affiliation": []}, {"given": "Alan P", "family": "Beresford", "sequence": "additional", "affiliation": []}, {"given": "Michael H", "family": "Tarbit", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Drug Discovery Today"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1359644601021006?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1359644601021006?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 29]], "date-time": "2019-04-29T04:52:46Z", "timestamp": 1556513566000}, "score": 30.28501, "issued": {"date-parts": [[2002, 1]]}, "references-count": 16, "journal-issue": {"published-print": {"date-parts": [[2002, 1]]}, "issue": "2"}, "alternative-id": ["S1359644601021006"], "URL": "http://dx.doi.org/10.1016/s1359-6446(01)02100-6", "ISSN": ["1359-6446"], "issn-type": [{"value": "1359-6446", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T04:14:50Z", "timestamp": 1574482490613}, "reference-count": 46, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2010, 1, 1]], "date-time": "2010-01-01T00:00:00Z", "timestamp": 1262304000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drug Discovery Today: Technologies"], "published-print": {"date-parts": [[2010]]}, "DOI": "10.1016/j.ddtec.2010.11.002", "type": "journal-article", "created": {"date-parts": [[2010, 12, 4]], "date-time": "2010-12-04T09:50:23Z", "timestamp": 1291456223000}, "page": "e149-e156", "source": "Crossref", "is-referenced-by-count": 14, "title": ["In silico docking and scoring of fragments"], "prefix": "10.1016", "volume": "7", "author": [{"given": "Yu", "family": "Chen", "sequence": "first", "affiliation": []}, {"given": "Denise Teotico", "family": "Pohlhaus", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Drug Discovery Today: Technologies"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1740674910000351?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1740674910000351?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 6]], "date-time": "2018-12-06T11:28:44Z", "timestamp": 1544095724000}, "score": 29.325857, "issued": {"date-parts": [[2010]]}, "references-count": 46, "journal-issue": {"published-print": {"date-parts": [[2010]]}, "issue": "3"}, "alternative-id": ["S1740674910000351"], "URL": "http://dx.doi.org/10.1016/j.ddtec.2010.11.002", "ISSN": ["1740-6749"], "issn-type": [{"value": "1740-6749", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T04:18:53Z", "timestamp": 1574137133954}, "reference-count": 25, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2004, 10, 1]], "date-time": "2004-10-01T00:00:00Z", "timestamp": 1096588800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drug Discovery Today: Technologies"], "published-print": {"date-parts": [[2004, 10]]}, "DOI": "10.1016/j.ddtec.2004.08.007", "type": "journal-article", "created": {"date-parts": [[2004, 9, 8]], "date-time": "2004-09-08T14:33:15Z", "timestamp": 1094653995000}, "page": "105-111", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Functional genomics and target gene validation in experimental and human disease"], "prefix": "10.1016", "volume": "1", "author": [{"given": "Johannes H.", "family": "Schulte", "sequence": "first", "affiliation": []}, {"given": "Julika", "family": "Pitsch", "sequence": "additional", "affiliation": []}, {"given": "Albert J.", "family": "Becker", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Drug Discovery Today: Technologies"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1740674904000174?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1740674904000174?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 4]], "date-time": "2019-02-04T03:22:32Z", "timestamp": 1549250552000}, "score": 28.40383, "issued": {"date-parts": [[2004, 10]]}, "references-count": 25, "journal-issue": {"published-print": {"date-parts": [[2004, 10]]}, "issue": "2"}, "alternative-id": ["S1740674904000174"], "URL": "http://dx.doi.org/10.1016/j.ddtec.2004.08.007", "ISSN": ["1740-6749"], "issn-type": [{"value": "1740-6749", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T03:22:07Z", "timestamp": 1574479327817}, "reference-count": 35, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2010, 12, 1]], "date-time": "2010-12-01T00:00:00Z", "timestamp": 1291161600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drug Discovery Today: Technologies"], "published-print": {"date-parts": [[2010, 12]]}, "DOI": "10.1016/j.ddtec.2010.10.003", "type": "journal-article", "created": {"date-parts": [[2010, 11, 17]], "date-time": "2010-11-17T09:45:43Z", "timestamp": 1289987143000}, "page": "e245-e253", "source": "Crossref", "is-referenced-by-count": 42, "title": ["Conformations and 3D pharmacophore searching"], "prefix": "10.1016", "volume": "7", "author": [{"given": "Christof H.", "family": "Schwab", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Drug Discovery Today: Technologies"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1740674910000326?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1740674910000326?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 6]], "date-time": "2018-12-06T20:01:16Z", "timestamp": 1544126476000}, "score": 27.877249, "issued": {"date-parts": [[2010, 12]]}, "references-count": 35, "journal-issue": {"published-print": {"date-parts": [[2010, 12]]}, "issue": "4"}, "alternative-id": ["S1740674910000326"], "URL": "http://dx.doi.org/10.1016/j.ddtec.2010.10.003", "ISSN": ["1740-6749"], "issn-type": [{"value": "1740-6749", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T08:05:01Z", "timestamp": 1574496301895}, "publisher-location": "Hoboken, NJ, USA", "reference-count": 55, "publisher": "John Wiley & Sons, Inc.", "isbn-type": [{"value": "9781118101186", "type": "print"}, {"value": "9781118435762", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1002/9781118435762.ch6", "type": "book-chapter", "created": {"date-parts": [[2012, 8, 10]], "date-time": "2012-08-10T13:20:14Z", "timestamp": 1344604814000}, "page": "101-114", "source": "Crossref", "is-referenced-by-count": 1, "title": ["ADME Properties of Drugs"], "prefix": "10.1002", "author": [{"given": "Li", "family": "Di", "sequence": "first", "affiliation": []}, {"given": "Edward H.", "family": "Kerns", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2012, 8, 10]]}, "reference": [{"key": "10.1002/9781118435762.ch6-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "417", "DOI": "10.1038/nrd1382", "article-title": "Key factors in the rising cost of new drug discovery and development", "volume": "3", "author": "Dickson", "year": "2004", "journal-title": "Nature Rev. Drug Disc."}, {"key": "10.1002/9781118435762.ch6-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "255", "DOI": "10.1016/j.cbpa.2004.04.003", "article-title": "Pursuing the leadlikeness concept in pharmaceutical research", "volume": "8", "author": "Hann", "year": "2004", "journal-title": "Curr. Opin. Chem. Biol."}, {"key": "10.1002/9781118435762.ch6-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "711", "DOI": "10.1038/nrd1470", "article-title": "Can the pharmaceutical industry reduce attrition rate?", "volume": "3", "author": "Kola", "year": "2004", "journal-title": "Nature Rev. Drug Disc."}, {"key": "10.1002/9781118435762.ch6-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "387", "DOI": "10.1111/j.1365-2125.1988.tb03318.x", "article-title": "Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985)", "volume": "25", "author": "Prentis", "year": "1988", "journal-title": "Br. J. Clin. Pharmacol."}, {"key": "10.1002/9781118435762.ch6-BIB5|cit5", "author": "Kerns", "year": "2008", "volume-title": "Drug-Like Properties: Concepts, Structure Design and Methodology"}, {"key": "10.1002/9781118435762.ch6-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "1313", "DOI": "10.1021/jm000407e", "article-title": "Property-based design: optimization of drug absorption and pharmacokinetics", "volume": "44", "author": "van de Waterbeemd", "year": "2001", "journal-title": "J. Med. Chem."}, {"key": "10.1002/9781118435762.ch6-BIB7|cit7", "author": "Hann", "first-page": "130", "year": "1994", "volume-title": "Medicinal Chemistry. Principles and Practice"}, {"key": "10.1002/9781118435762.ch6-BIB8|cit8", "first-page": "495", "article-title": "Application of pharmaceutical profiling assays for optimization of drug-like properties", "volume": "8", "author": "Di", "year": "2005", "journal-title": "Curr. Opin. Drug Disc. Devel."}, {"key": "10.1002/9781118435762.ch6-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "316", "DOI": "10.1016/S1359-6446(03)02649-7", "article-title": "Pharmaceutical profiling in drug discovery", "volume": "8", "author": "Kerns", "year": "2003", "journal-title": "Drug Disc. Today"}, {"key": "10.1002/9781118435762.ch6-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "3", "DOI": "10.1016/S0169-409X(96)00423-1", "article-title": "Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings", "volume": "23", "author": "Lipinski", "year": "1997", "journal-title": "Adv. Drug Del. Rev."}, {"key": "10.1002/9781118435762.ch6-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "446", "DOI": "10.1016/j.drudis.2006.03.004", "article-title": "Biological assay challenges from compound solubility: strategies for bioassay optimization", "volume": "11", "author": "Di", "year": "2006", "journal-title": "Drug Disc. Today"}, {"key": "10.1002/9781118435762.ch6-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "1838", "DOI": "10.1002/jps.1134", "article-title": "High throughput physicochemical profiling for drug discovery", "volume": "90", "author": "Kerns", "year": "2001", "journal-title": "J. Pharmaceut. Sci."}, {"key": "10.1002/9781118435762.ch6-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "277", "DOI": "10.2174/1568026013395100", "article-title": "Physicochemical profiling (solubility, permeability and charge state)", "volume": "1", "author": "Avdeef", "year": "2001", "journal-title": "Curr. Topics Med. Chem."}, {"key": "10.1002/9781118435762.ch6-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "1781", "DOI": "10.1021/ac9912247", "article-title": "A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates", "volume": "72", "author": "Bevan", "year": "2000", "journal-title": "Anal. Chem."}, {"key": "10.1002/9781118435762.ch6-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "67", "DOI": "10.1016/j.ddtec.2005.03.001", "article-title": "Rationale and benefit of using high throughput solubility screens in drug discovery", "volume": "3", "author": "Goodwin", "year": "2006", "journal-title": "Drug Disc. Today: Technol."}, {"key": "10.1002/9781118435762.ch6-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "357", "DOI": "10.1016/S1359-6446(01)01712-3", "article-title": "Screening for human ADME/Tox drug properties in drug discovery", "volume": "6", "author": "Li", "year": "2001", "journal-title": "Drug Disc. Today"}, {"key": "10.1002/9781118435762.ch6-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "3867", "DOI": "10.1021/jm000292e", "article-title": "Prediction of drug absorption using multivariate statistics", "volume": "43", "author": "Egan", "year": "2000", "journal-title": "J. Med. Chem."}, {"key": "10.1002/9781118435762.ch6-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "1007", "DOI": "10.1021/jm970530e", "article-title": "Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes", "volume": "41", "author": "Kansy", "year": "1998", "journal-title": "J. Med. Chem."}, {"key": "10.1002/9781118435762.ch6-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "325", "DOI": "10.1517/17425255.1.2.325", "article-title": "The rise of PAMPA", "volume": "1", "author": "Avdeef", "year": "2005", "journal-title": "Expert Opin. Drug Metabol. Toxicol."}, {"key": "10.1002/9781118435762.ch6-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "241", "DOI": "10.1016/S0378-5173(02)00240-5", "article-title": "Prediction of passive intestinal absorption using bio-mimetic artificial membrane permeation assay and the paracellular pathway model", "volume": "241", "author": "Sugano", "year": "2002", "journal-title": "Intl. J. Pharmaceut."}, {"key": "10.1002/9781118435762.ch6-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "223", "DOI": "10.1016/S0223-5234(03)00012-6", "article-title": "High throughput artificial membrane permeability assay for blood-brain barrier", "volume": "38", "author": "Di", "year": "2003", "journal-title": "Euro. J. Med. Chem."}, {"key": "10.1002/9781118435762.ch6-BIB22|cit22", "doi-asserted-by": "crossref", "first-page": "3948", "DOI": "10.1021/jm060230+", "article-title": "Parallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeability", "volume": "49", "author": "Ottaviani", "year": "2006", "journal-title": "J. Med. Chem."}, {"key": "10.1002/9781118435762.ch6-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "1440", "DOI": "10.1002/jps.20075", "article-title": "Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery", "volume": "93", "author": "Kerns", "year": "2004", "journal-title": "J. Pharmaceut. Sci."}, {"key": "10.1002/9781118435762.ch6-BIB24|cit24", "doi-asserted-by": "crossref", "first-page": "3", "DOI": "10.1007/s10822-006-9101-z", "article-title": "Comparative QSAR studies on PAMPA/modified PAMPA for high throughput profiling of drug absorption potential with respect to Caco-2 cells and human intestinal absorption", "volume": "21", "author": "Verma", "year": "2007", "journal-title": "J. Computer-Aided Molec. Design"}, {"key": "10.1002/9781118435762.ch6-BIB25|cit25", "doi-asserted-by": "crossref", "first-page": "99", "DOI": "10.1016/j.ejpb.2004.02.014", "article-title": "Utility of 96 well Caco-2 cell system for increased throughput of P-gp screening in drug discovery", "volume": "58", "author": "Balimane", "year": "2004", "journal-title": "Euro. J. Pharmaceut. Biopharmaceut."}, {"key": "10.1002/9781118435762.ch6-BIB26|cit26", "doi-asserted-by": "crossref", "first-page": "1029", "DOI": "10.1124/jpet.102.039255", "article-title": "Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs", "volume": "303", "author": "Doan", "year": "2002", "journal-title": "J. Pharmacol. Experim. Therapeut."}, {"key": "10.1002/9781118435762.ch6-BIB27|cit27", "doi-asserted-by": "crossref", "first-page": "192", "DOI": "10.1038/nrd1032", "article-title": "ADMET in silico modelling: towards prediction paradise?", "volume": "2", "author": "van de Waterbeemd", "year": "2003", "journal-title": "Nature Rev. Drug Disc."}, {"key": "10.1002/9781118435762.ch6-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "453", "DOI": "10.1177/1087057103255988", "article-title": "Optimization of a higher throughput microsomal stability screening assay for profiling drug discovery candidates", "volume": "8", "author": "Di", "year": "2003", "journal-title": "J. Biomol. Screen."}, {"key": "10.1002/9781118435762.ch6-BIB29|cit29", "doi-asserted-by": "crossref", "first-page": "54", "DOI": "10.1016/j.ijpharm.2006.03.007", "article-title": "High throughput microsomal stability assay for insoluble compounds", "volume": "317", "author": "Di", "year": "2006", "journal-title": "Intl. J. Pharmaceut."}, {"key": "10.1002/9781118435762.ch6-BIB30|cit30", "doi-asserted-by": "crossref", "first-page": "16", "DOI": "10.1016/j.cbi.2007.01.001", "article-title": "Human hepatocytes: isolation, cryopreservation and applications in drug development", "volume": "168", "author": "Li", "year": "2007", "journal-title": "Chemico-Biological Interact"}, {"key": "10.1002/9781118435762.ch6-BIB31|cit31", "doi-asserted-by": "crossref", "first-page": "1531", "DOI": "10.1016/j.bcp.2005.12.019", "article-title": "In vitro-in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: pitfalls and promises", "volume": "71", "author": "Miners", "year": "2006", "journal-title": "Biochem. Pharmacol."}, {"key": "10.1002/9781118435762.ch6-BIB32|cit32", "doi-asserted-by": "crossref", "first-page": "110", "DOI": "10.1016/j.ijpharm.2005.03.022", "article-title": "Development and application of high throughput plasma stability assay for drug discovery", "volume": "297", "author": "Di", "year": "2005", "journal-title": "Internat. J. Pharmaceut."}, {"key": "10.1002/9781118435762.ch6-BIB33|cit33", "doi-asserted-by": "crossref", "first-page": "40", "DOI": "10.1177/1087057105281363", "article-title": "Development and application of an automated solution stability assay for drug discovery", "volume": "11", "author": "Di", "year": "2006", "journal-title": "J. Biomolec. Screen."}, {"key": "10.1002/9781118435762.ch6-BIB34|cit34", "doi-asserted-by": "crossref", "first-page": "889", "DOI": "10.2217/14622416.7.6.889", "article-title": "Can pharmacogenetics help rescue drugs withdrawn from the market?", "volume": "7", "author": "Shah", "year": "2006", "journal-title": "Pharmacogenomics"}, {"key": "10.1002/9781118435762.ch6-BIB35|cit35", "author": "Rodrigues", "year": "2002", "volume-title": "Drug-Drug Interactions"}, {"key": "10.1002/9781118435762.ch6-BIB36|cit36", "doi-asserted-by": "crossref", "first-page": "815", "DOI": "10.1124/dmd.31.7.815", "article-title": "The conduct of in vitro and in vivo drug-drug interaction studies: a pharmaceutical and manufacturers of America (PhRMA) perspective", "volume": "31", "author": "Bjornsson", "year": "2003", "journal-title": "Drug Metab. Dispos."}, {"key": "10.1002/9781118435762.ch6-BIB37|cit37", "doi-asserted-by": "crossref", "first-page": "1443", "DOI": "10.1016/S1359-6446(05)03580-4", "article-title": "High throughput P450 inhibition screens in early drug discovery", "volume": "10", "author": "Zlokarnik", "year": "2005", "journal-title": "Drug Disc. Today"}, {"key": "10.1002/9781118435762.ch6-BIB38|cit38", "doi-asserted-by": "crossref", "first-page": "188", "DOI": "10.1006/abio.1997.2145", "article-title": "Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450", "volume": "248", "author": "Crespi", "year": "1997", "journal-title": "Anal. Biochem."}, {"key": "10.1002/9781118435762.ch6-BIB39|cit39", "doi-asserted-by": "crossref", "first-page": "983", "DOI": "10.1073/pnas.0406755102", "article-title": "Metabolizing enzyme toxicology assay chip (MetaChip) for high-throughput microscale toxicity analyses", "volume": "102", "author": "Lee", "year": "2005", "journal-title": "Proc. Natl. Acad. Sci. U.S.A."}, {"key": "10.1002/9781118435762.ch6-BIB40|cit40", "doi-asserted-by": "crossref", "first-page": "647", "DOI": "10.1124/dmd.32.6.647", "article-title": "Validated assays for human cytochrome p450 activities", "volume": "32", "author": "Walsky", "year": "2004", "journal-title": "Drug Metab. Dispos."}, {"key": "10.1002/9781118435762.ch6-BIB41|cit41", "first-page": "23", "article-title": "A method for the simultaneous evaluation of the activities of seven major human drug-metabolizing cytochrome P450s using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry", "volume": "29", "author": "Dierks", "year": "2001", "journal-title": "Drug Metab. Dispos."}, {"key": "10.1002/9781118435762.ch6-BIB42|cit42", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/j.ijpharm.2006.10.039", "article-title": "Comparison of cytochrome P450 inhibition assays for drug discovery using human liver microsomes with LC-MS, rhCYP450 isozymes with fluorescence, and double cocktail with LC-MS", "volume": "335", "author": "Di", "year": "2007", "journal-title": "Internat. J. Pharmaceut."}, {"key": "10.1002/9781118435762.ch6-BIB43|cit43", "doi-asserted-by": "crossref", "first-page": "955", "DOI": "10.1124/dmd.31.7.955", "article-title": "Cytochrome P450 Inhibition using recombinant proteins and mass spectrometry/multiple reaction monitoring technology in a cassette incubation", "volume": "31", "author": "Weaver", "year": "2003", "journal-title": "Drug Metab. Dispos."}, {"key": "10.1002/9781118435762.ch6-BIB44|cit44", "doi-asserted-by": "crossref", "first-page": "629", "DOI": "10.1517/17425255.2.4.629", "article-title": "Luminogenic cytochrome P450 assays", "volume": "2", "author": "Cali", "year": "2006", "journal-title": "Expert Opin. Drug Metab. Toxicol."}, {"key": "10.1002/9781118435762.ch6-BIB46|cit46", "year": "2006", "volume-title": "Optimizing the \u201cDrug-Like\u201d Properties of Leads in Drug Discovery"}, {"key": "10.1002/9781118435762.ch6-BIB47|cit47", "year": "2004", "volume-title": "Proceedings of the Workshop held May 19-21, 2003 in Whippany, New Jersey"}, {"key": "10.1002/9781118435762.ch6-BIB48|cit48", "author": "Dressman", "year": "2000", "volume-title": "Oral Drug Absorption: Prediction and Assessment", "DOI": "10.1201/b15445", "doi-asserted-by": "crossref"}, {"key": "10.1002/9781118435762.ch6-BIB49|cit49", "unstructured": "Kerns EH Di L. 2008"}, {"key": "10.1002/9781118435762.ch6-BIB50|cit50", "author": "Lee", "year": "2003", "volume-title": "Drug Metabolizing Enzymes: Cytochrome P450 and Other Enzymes in Drug Discovery and Development", "DOI": "10.1201/9781420028485", "doi-asserted-by": "crossref"}, {"key": "10.1002/9781118435762.ch6-BIB51|cit51", "author": "Pardridge", "year": "2006", "volume-title": "Introduction to the Blood-Brain Barrier"}, {"key": "10.1002/9781118435762.ch6-BIB52|cit52", "author": "Skett", "year": "2001", "volume-title": "Introduction to Drug Metabolism"}, {"key": "10.1002/9781118435762.ch6-BIB53|cit53", "author": "Smith", "year": "2001", "volume-title": "Pharmacokinetics and Metabolism in Drug Design", "DOI": "10.1002/3527600213", "doi-asserted-by": "crossref"}, {"key": "10.1002/9781118435762.ch6-BIB54|cit54", "author": "Testa", "year": "2001", "volume-title": "Pharmacokinetic Optimization in Drug Research: Biological, Physiological, and Computational Strategies", "DOI": "10.1002/9783906390437", "doi-asserted-by": "crossref"}, {"key": "10.1002/9781118435762.ch6-BIB55|cit55", "author": "van de Waterbeemd", "year": "2003", "volume-title": "Drug Bioavailability: Estimation of Solubility, Permeability, Absorption and Bioavailability", "DOI": "10.1002/3527601473", "doi-asserted-by": "crossref"}, {"key": "10.1002/9781118435762.ch6-BIB56|cit56", "year": "2004", "volume-title": "Optimization in Drug Discovery: In Vitro Methods"}], "container-title": ["Chemical Biology"], "link": [{"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/9781118435762.ch6", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 7, 2]], "date-time": "2019-07-02T18:36:43Z", "timestamp": 1562092603000}, "score": 27.680794, "issued": {"date-parts": [[2012, 8, 10]]}, "ISBN": ["9781118435762", "9781118101186"], "references-count": 55, "URL": "http://dx.doi.org/10.1002/9781118435762.ch6", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T07:39:35Z", "timestamp": 1574753975927}, "publisher-location": "Hoboken, NJ, USA", "reference-count": 59, "publisher": "John Wiley & Sons, Inc.", "isbn-type": [{"value": "9780470571224", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1002/9780470571224.pse540", "type": "reference-entry", "created": {"date-parts": [[2015, 12, 30]], "date-time": "2015-12-30T06:59:02Z", "timestamp": 1451458742000}, "page": "1-11", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Overview of ADME and PK/PD of ADCs"], "prefix": "10.1002", "author": [{"given": "Baiteng", "family": "Zhao", "sequence": "first", "affiliation": [{"name": "Seattle Genetics Inc.; Bothell WA USA"}]}, {"given": "Tae H.", "family": "Han", "sequence": "additional", "affiliation": [{"name": "Stemcentrx, Inc.; South San Francisco CA USA"}]}], "member": "311", "published-online": {"date-parts": [[2015, 12, 30]]}, "reference": [{"key": "10.1002/9780470571224.pse540-BIB0001|pse540-cit-0001", "doi-asserted-by": "crossref", "first-page": "154", "DOI": "10.1097/PPO.0b013e318172d704", "article-title": "Antibody-drug conjugates for cancer therapy", "volume": "14", "author": "Carter", "year": "2008", "journal-title": "Cancer J"}, {"key": "10.1002/9780470571224.pse540-BIB0002|pse540-cit-0002", "doi-asserted-by": "crossref", "first-page": "473", "DOI": "10.1038/nrc2394", "article-title": "Paul Ehrlich's magic bullet concept: 100 years of progress", "volume": "8", "author": "Strebhardt", "year": "2008", "journal-title": "Nat Rev Cancer"}, {"key": "10.1002/9780470571224.pse540-BIB0003|pse540-cit-0003", "first-page": "1490", "article-title": "Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia", "volume": "7", "author": "Bross", "year": "2001", "journal-title": "Clin Cancer Res"}, {"key": "10.1002/9780470571224.pse540-BIB0004|pse540-cit-0004", "doi-asserted-by": "crossref", "first-page": "1914", "DOI": "10.1124/dmd.114.058586", "article-title": "Absorption, distribution, metabolism, and excretion considerations for the development of antibody-drug conjugates", "volume": "42", "author": "Han", "year": "2014", "journal-title": "Drug Metab Dispos"}, {"key": "10.1002/9780470571224.pse540-BIB0005|pse540-cit-0005", "doi-asserted-by": "crossref", "first-page": "932", "DOI": "10.1124/jpet.109.155549", "article-title": "The pharmacologic basis for antibody-auristatin conjugate activity", "volume": "330", "author": "Alley", "year": "2009", "journal-title": "J Pharmacol Exp Ther"}, {"key": "10.1002/9780470571224.pse540-BIB0006|pse540-cit-0006", "doi-asserted-by": "crossref", "first-page": "445", "DOI": "10.1111/j.1476-5381.2012.02138.x", "article-title": "An integrated approach to identify normal tissue expression of targets for antibody-drug conjugates: case study of TENB2", "volume": "168", "author": "Boswell", "year": "2013", "journal-title": "Br J Pharmacol"}, {"key": "10.1002/9780470571224.pse540-BIB0007|pse540-cit-0007", "doi-asserted-by": "crossref", "first-page": "1454", "DOI": "10.2967/jnumed.112.103168", "article-title": "Differential effects of predosing on tumor and tissue uptake of an 111In-labeled anti-TENB2 antibody-drug conjugate", "volume": "53", "author": "Boswell", "year": "2012", "journal-title": "J Nucl Med"}, {"key": "10.1002/9780470571224.pse540-BIB0008|pse540-cit-0008", "doi-asserted-by": "crossref", "first-page": "2153", "DOI": "10.1021/bc100261d", "article-title": "Effects of charge on antibody tissue distribution and pharmacokinetics", "volume": "21", "author": "Boswell", "year": "2010", "journal-title": "Bioconjug Chem"}, {"key": "10.1002/9780470571224.pse540-BIB0009|pse540-cit-0009", "doi-asserted-by": "crossref", "first-page": "1008", "DOI": "10.1021/bc4000564", "article-title": "Conjugation site heterogeneity causes variable electrostatic properties in Fc conjugates", "volume": "24", "author": "Boylan", "year": "2013", "journal-title": "Bioconjug Chem"}, {"key": "10.1002/9780470571224.pse540-BIB0010|pse540-cit-0010", "doi-asserted-by": "crossref", "first-page": "689", "DOI": "10.4161/mabs.28254", "article-title": "Quantitative cumulative biodistribution of antibodies in mice: effect of modulating binding affinity to the neonatal Fc receptor", "volume": "6", "author": "Yip", "year": "2014", "journal-title": "MAbs"}, {"key": "10.1002/9780470571224.pse540-BIB0011|pse540-cit-0011", "doi-asserted-by": "crossref", "first-page": "7842", "DOI": "10.1158/1078-0432.CCR-04-1028", "article-title": "Efficient elimination of B-lineage lymphomas by anti-CD20-auristatin conjugates", "volume": "10", "author": "Law", "year": "2004", "journal-title": "Clin Cancer Res"}, {"key": "10.1002/9780470571224.pse540-BIB0012|pse540-cit-0012", "doi-asserted-by": "crossref", "first-page": "1214", "DOI": "10.1158/0008-5472.CAN-13-2440", "article-title": "An antibody-drug conjugate that targets tissue factor exhibits potent therapeutic activity against a broad range of solid tumors", "volume": "74", "author": "Breij", "year": "2014", "journal-title": "Cancer Res"}, {"key": "10.1002/9780470571224.pse540-BIB0013|pse540-cit-0013", "doi-asserted-by": "crossref", "first-page": "126", "DOI": "10.1038/clpt.2013.78", "article-title": "Intracellular drug concentrations and transporters: measurement, modeling, and implications for the liver", "volume": "94", "author": "Chu", "year": "2013", "journal-title": "Clin Pharmacol Ther"}, {"key": "10.1002/9780470571224.pse540-BIB0014|pse540-cit-0014", "author": "Genentech", "year": "2013", "volume-title": "KADCYLA\u2122 Prescribing Information"}, {"key": "10.1002/9780470571224.pse540-BIB0015|pse540-cit-0015", "author": "Seattle Genetics Inc.", "year": "2011", "volume-title": "ADCETRISTM Prescribing Information"}, {"key": "10.1002/9780470571224.pse540-BIB0016|pse540-cit-0016", "doi-asserted-by": "crossref", "first-page": "930", "DOI": "10.2174/138920012802138642", "article-title": "Effects of interleukin 1beta (IL-1beta) and IL-1beta/interleukin 6 (IL-6) combinations on drug metabolizing enzymes in human hepatocyte culture", "volume": "13", "author": "Dickmann", "year": "2012", "journal-title": "Curr Drug Metab"}, {"key": "10.1002/9780470571224.pse540-BIB0017|pse540-cit-0017", "doi-asserted-by": "crossref", "first-page": "1598", "DOI": "10.1124/dmd.113.052225", "article-title": "Critical review of preclinical approaches to investigate cytochrome p450-mediated therapeutic protein drug-drug interactions and recommendations for best practices: a white paper", "volume": "41", "author": "Evers", "year": "2013", "journal-title": "Drug Metab Dispos"}, {"key": "10.1002/9780470571224.pse540-BIB0018|pse540-cit-0018", "doi-asserted-by": "crossref", "first-page": "933", "DOI": "10.1208/s12248-013-9495-1", "article-title": "Therapeutic protein drug-drug interactions: navigating the knowledge gaps-highlights from the 2012 AAPS NBC Roundtable and IQ Consortium/FDA workshop", "volume": "15", "author": "Kenny", "year": "2013", "journal-title": "AAPS J"}, {"key": "10.1002/9780470571224.pse540-BIB0019|pse540-cit-0019", "first-page": "215", "article-title": "Drug interactions of cytokines and anticytokine therapeutic proteins", "volume": "13", "author": "Slatter", "year": "2013", "journal-title": "Pharm Sci Encycl"}, {"key": "10.1002/9780470571224.pse540-BIB0020|pse540-cit-0020", "doi-asserted-by": "crossref", "first-page": "1399", "DOI": "10.4155/bio.11.88", "article-title": "MALDI imaging techniques dedicated to drug-distribution studies", "volume": "3", "author": "Bonnel", "year": "2011", "journal-title": "Bioanalysis"}, {"key": "10.1002/9780470571224.pse540-BIB0021|pse540-cit-0021", "doi-asserted-by": "crossref", "first-page": "3420", "DOI": "10.1021/ac403860c", "article-title": "Measurement of in vivo drug load distribution of cysteine-linked antibody-drug conjugates using microscale liquid chromatography mass spectrometry", "volume": "86", "author": "Hengel", "year": "2014", "journal-title": "Anal Chem"}, {"issue": "4", "key": "10.1002/9780470571224.pse540-BIB0022|pse540-cit-0022", "doi-asserted-by": "crossref", "first-page": "656", "DOI": "10.1021/bc400439x", "article-title": "Auristatin antibody drug conjugate physical instability and the role of drug payload", "volume": "25", "author": "Adem", "year": "2014", "journal-title": "Bioconjug Chem"}, {"key": "10.1002/9780470571224.pse540-BIB0023|pse540-cit-0023", "doi-asserted-by": "crossref", "first-page": "1710", "DOI": "10.1007/s11095-013-1274-2", "article-title": "Assessment of physical stability of an antibody drug conjugate by higher order structure analysis: impact of thiol-maleimide chemistry", "volume": "31", "author": "Guo", "year": "2014", "journal-title": "Pharm Res"}, {"key": "10.1002/9780470571224.pse540-BIB0024|pse540-cit-0024", "doi-asserted-by": "crossref", "first-page": "1674", "DOI": "10.1021/bc400182x", "article-title": "Investigation into temperature-induced aggregation of an antibody drug conjugate", "volume": "24", "author": "Beckley", "year": "2013", "journal-title": "Bioconjug Chem"}, {"key": "10.1002/9780470571224.pse540-BIB0025|pse540-cit-0025", "doi-asserted-by": "crossref", "first-page": "1848", "DOI": "10.1182/blood-2007-07-099317", "article-title": "A phase 1 multidose study of SGN-30 immunotherapy in patients with refractory or recurrent CD30+ hematologic malignancies", "volume": "111", "author": "Bartlett", "year": "2008", "journal-title": "Blood"}, {"key": "10.1002/9780470571224.pse540-BIB0026|pse540-cit-0026", "doi-asserted-by": "crossref", "first-page": "1812", "DOI": "10.1056/NEJMoa1002965", "article-title": "Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas", "volume": "363", "author": "Younes", "year": "2010", "journal-title": "N Engl J Med"}, {"key": "10.1002/9780470571224.pse540-BIB0027|pse540-cit-0027", "doi-asserted-by": "crossref", "first-page": "7063", "DOI": "10.1158/1078-0432.CCR-04-0789", "article-title": "Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate", "volume": "10", "author": "Hamblett", "year": "2004", "journal-title": "Clin Cancer Res"}, {"key": "10.1002/9780470571224.pse540-BIB0028|pse540-cit-0028", "first-page": "2905", "article-title": "Isolation and characterization of early endosomes, late endosomes and terminal lysosomes: their role in protein degradation", "volume": "109", "author": "Tjelle", "year": "1996", "journal-title": "J Cell Sci"}, {"key": "10.1002/9780470571224.pse540-BIB0029|pse540-cit-0029", "doi-asserted-by": "crossref", "first-page": "866", "DOI": "10.1002/jcph.116", "article-title": "CYP3A-mediated drug-drug interaction potential and excretion of brentuximab vedotin, an antibody-drug conjugate, in patients with CD30-positive hematologic malignancies", "volume": "53", "author": "Han", "year": "2013", "journal-title": "J Clin Pharmacol"}, {"key": "10.1002/9780470571224.pse540-BIB0030|pse540-cit-0030", "unstructured": "FDA Center for Drug Evaluation and Research US 2011 Clinical pharmacology and biopharmaceutics review(s)"}, {"key": "10.1002/9780470571224.pse540-BIB0031|pse540-cit-0031", "unstructured": "FDA Center for Drug Evaluation and Research US 2013 Clinical pharmacology and biopharmaceutics review(s)"}, {"key": "10.1002/9780470571224.pse540-BIB0032|pse540-cit-0032", "doi-asserted-by": "crossref", "first-page": "901", "DOI": "10.2174/138920012802138598", "article-title": "Catabolic fate and pharmacokinetic characterization of trastuzumab emtansine (T-DM1): an emphasis on preclinical and clinical catabolism", "volume": "13", "author": "Shen", "year": "2012a", "journal-title": "Curr Drug Metab"}, {"key": "10.1002/9780470571224.pse540-BIB0033|pse540-cit-0033", "doi-asserted-by": "crossref", "first-page": "1927", "DOI": "10.1124/dmd.112.046169", "article-title": "In vitro characterization of the drug-drug interaction potential of catabolites of antibody-maytansinoid conjugates", "volume": "40", "author": "Davis", "year": "2012", "journal-title": "Drug Metab Dispos"}, {"key": "10.1002/9780470571224.pse540-BIB0034|pse540-cit-0034", "doi-asserted-by": "crossref", "first-page": "799", "DOI": "10.1208/s12248-012-9386-x", "article-title": "ADME of antibody-maytansinoid conjugates", "volume": "14", "author": "Erickson", "year": "2012", "journal-title": "AAPS J"}, {"key": "10.1002/9780470571224.pse540-BIB0035|pse540-cit-0035", "doi-asserted-by": "crossref", "first-page": "728", "DOI": "10.1021/bc100498q", "article-title": "Design of antibody-maytansinoid conjugates allows for efficient detoxification via liver metabolism", "volume": "22", "author": "Sun", "year": "2011", "journal-title": "Bioconjug Chem"}, {"key": "10.1002/9780470571224.pse540-BIB0036|pse540-cit-0036", "doi-asserted-by": "crossref", "first-page": "235", "DOI": "10.1016/j.cbpa.2009.03.023", "article-title": "Potent antibody drug conjugates for cancer therapy", "volume": "13", "author": "Senter", "year": "2009", "journal-title": "Curr Opin Chem Biol"}, {"issue": "19 Suppl", "key": "10.1002/9780470571224.pse540-BIB0037|pse540-cit-0037", "doi-asserted-by": "crossref", "first-page": "1786", "DOI": "10.1158/1538-7445.AM2014-1786", "article-title": "Development and pharmacological properties of PEGylated glucuronide-auristatin linkers", "volume": "74", "author": "Burke", "year": "2014", "journal-title": "Cancer Res"}, {"key": "10.1002/9780470571224.pse540-BIB0038|pse540-cit-0038", "doi-asserted-by": "crossref", "first-page": "778", "DOI": "10.1038/nbt832", "article-title": "Development of potent monoclonal antibody auristatin conjugates for cancer therapy", "volume": "21", "author": "Doronina", "year": "2003", "journal-title": "Nat Biotechnol"}, {"key": "10.1002/9780470571224.pse540-BIB0039|pse540-cit-0039", "doi-asserted-by": "crossref", "first-page": "6437", "DOI": "10.1158/1078-0432.CCR-11-0762", "article-title": "Trastuzumab emtansine: a unique antibody-drug conjugate in development for human epidermal growth factor receptor 2-positive cancer", "volume": "17", "author": "Lorusso", "year": "2011", "journal-title": "Clin Cancer Res"}, {"key": "10.1002/9780470571224.pse540-BIB0040|pse540-cit-0040", "doi-asserted-by": "crossref", "first-page": "4426", "DOI": "10.1158/0008-5472.CAN-05-4489", "article-title": "Antibody-maytansinoid conjugates are activated in targeted cancer cells by lysosomal degradation and linker-dependent intracellular processing", "volume": "66", "author": "Erickson", "year": "2006", "journal-title": "Cancer Res"}, {"key": "10.1002/9780470571224.pse540-BIB0041|pse540-cit-0041", "doi-asserted-by": "crossref", "first-page": "1133", "DOI": "10.1158/1535-7163.MCT-11-0727", "article-title": "The effect of different linkers on target cell catabolism and pharmacokinetics/pharmacodynamics of trastuzumab maytansinoid conjugates", "volume": "11", "author": "Erickson", "year": "2012", "journal-title": "Mol Cancer Ther"}, {"key": "10.1002/9780470571224.pse540-BIB0042|pse540-cit-0042", "doi-asserted-by": "crossref", "first-page": "184", "DOI": "10.1038/nbt.2108", "article-title": "Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates", "volume": "30", "author": "Shen", "year": "2012b", "journal-title": "Nat Biotechnol"}, {"key": "10.1002/9780470571224.pse540-BIB0043|pse540-cit-0043", "doi-asserted-by": "crossref", "first-page": "4333", "DOI": "10.1158/1538-7445.AM2013-4333", "article-title": "Self-stabilizing ADCs: antibody-drug conjugates prepared with maleimido drug-linkers that catalyze their own thiosuccinimide ring hydrolysis", "volume": "73", "author": "Lyon", "year": "2013", "journal-title": "Cancer Res"}, {"key": "10.1002/9780470571224.pse540-BIB0044|pse540-cit-0044", "doi-asserted-by": "crossref", "first-page": "4769", "DOI": "10.1158/1078-0432.CCR-10-0987", "article-title": "Engineered thio-trastuzumab-DM1 conjugate with an improved therapeutic index to target human epidermal growth factor receptor 2-positive breast cancer", "volume": "16", "author": "Junutula", "year": "2010", "journal-title": "Clin Cancer Res"}, {"key": "10.1002/9780470571224.pse540-BIB0045|pse540-cit-0045", "doi-asserted-by": "crossref", "first-page": "925", "DOI": "10.1038/nbt.1480", "article-title": "Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index", "volume": "26", "author": "Junutula", "year": "2008", "journal-title": "Nat Biotechnol"}, {"key": "10.1002/9780470571224.pse540-BIB0046|pse540-cit-0046", "doi-asserted-by": "crossref", "first-page": "657", "DOI": "10.1007/s40262-013-0060-y", "article-title": "An integrated multiple-analyte pharmacokinetic model to characterize trastuzumab emtansine (T-DM1) clearance pathways and to evaluate reduced pharmacokinetic sampling in patients with HER2-positive metastatic breast cancer", "volume": "52", "author": "Lu", "year": "2013", "journal-title": "Clin Pharmacokinet"}, {"key": "10.1002/9780470571224.pse540-BIB0047|pse540-cit-0047", "doi-asserted-by": "crossref", "first-page": "888", "DOI": "10.1158/1078-0432.CCR-09-2069", "article-title": "Intracellular activation of SGN-35, a potent anti-CD30 antibody-drug conjugate", "volume": "16", "author": "Okeley", "year": "2010", "journal-title": "Clin Cancer Res"}, {"key": "10.1002/9780470571224.pse540-BIB0048|pse540-cit-0048", "doi-asserted-by": "crossref", "first-page": "1229", "DOI": "10.1007/s00280-011-1817-3", "article-title": "Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody-drug conjugate in development for the treatment of HER2-positive cancer", "volume": "69", "author": "Girish", "year": "2012", "journal-title": "Cancer Chemother Pharmacol"}, {"key": "10.1002/9780470571224.pse540-BIB0049|pse540-cit-0049", "doi-asserted-by": "crossref", "first-page": "497", "DOI": "10.1038/clpt.2009.308", "article-title": "Therapeutic protein-drug interactions and implications for drug development", "volume": "87", "author": "Huang", "year": "2010", "journal-title": "Clin Pharmacol Ther"}, {"key": "10.1002/9780470571224.pse540-BIB0050|pse540-cit-0050", "doi-asserted-by": "crossref", "first-page": "1540", "DOI": "10.1177/0091270007308616", "article-title": "Drug interaction studies of therapeutic proteins or monoclonal antibodies", "volume": "47", "author": "Mahmood", "year": "2007", "journal-title": "J Clin Pharmacol"}, {"key": "10.1002/9780470571224.pse540-BIB0051|pse540-cit-0051", "doi-asserted-by": "crossref", "first-page": "1104", "DOI": "10.1177/0091270007306958", "article-title": "Pharmacokinetic drug-drug interaction potentials for therapeutic monoclonal antibodies: reality check", "volume": "47", "author": "Seitz", "year": "2007", "journal-title": "J Clin Pharmacol"}, {"key": "10.1002/9780470571224.pse540-BIB0052|pse540-cit-0052", "first-page": "S17", "article-title": "Effect of renal impairment on the pharmacokinetics of brentuximab vedotin, an antibody-drug conjugate, in patients with CD30-positive hematologic malignancie", "volume": "93", "author": "Han", "year": "2013", "journal-title": "Clin Pharmacol Ther"}, {"key": "10.1002/9780470571224.pse540-BIB0053|pse540-cit-0053", "first-page": "843", "article-title": "In vivo drug-linker stability of an anti-CD30 dipeptide-linked auristatin immunoconjugate", "volume": "11", "author": "Sanderson", "year": "2005", "journal-title": "Clin Cancer Res"}, {"key": "10.1002/9780470571224.pse540-BIB0054|pse540-cit-0054", "doi-asserted-by": "crossref", "first-page": "520", "DOI": "10.1038/clpt.2012.153", "article-title": "Semi-mechanistic population pharmacokinetic model of multivalent trastuzumab emtansine in patients with metastatic breast cancer", "volume": "92", "author": "Chudasama", "year": "2012", "journal-title": "Clin Pharmacol Ther"}, {"issue": "5", "key": "10.1002/9780470571224.pse540-BIB0055|pse540-cit-0055", "doi-asserted-by": "crossref", "first-page": "994", "DOI": "10.1208/s12248-014-9618-3", "article-title": "A mechanistic pharmacokinetic model elucidating the disposition of trastuzumab emtansine (T-DM1), an antibody-drug conjugate (ADC) for treatment of metastatic breast cancer", "volume": "16", "author": "Bender", "year": "2014", "journal-title": "AAPS J"}, {"key": "10.1002/9780470571224.pse540-BIB0056|pse540-cit-0056", "unstructured": "Lu D Ng C Agarwal P Girish S Li D Prabhu S Nazzal D Saad O Dere R Koppada N Jin J. American Conference on Pharmacometrics (ACoP) 2013 2013"}, {"key": "10.1002/9780470571224.pse540-BIB0057|pse540-cit-0057", "doi-asserted-by": "crossref", "first-page": "35", "DOI": "10.1007/s10928-013-9344-y", "article-title": "Target-mediated drug disposition model and its approximations for antibody-drug conjugates", "volume": "41", "author": "Gibiansky", "year": "2014", "journal-title": "J Pharmacokinet Pharmacodyn"}, {"key": "10.1002/9780470571224.pse540-BIB0058|pse540-cit-0058", "doi-asserted-by": "crossref", "first-page": "643", "DOI": "10.1007/s10928-012-9276-y", "article-title": "Bench to bedside translation of antibody drug conjugates using a multiscale mechanistic PK/PD model: a case study with brentuximab-vedotin", "volume": "39", "author": "Shah", "year": "2012", "journal-title": "J Pharmacokinet Pharmacodyn"}, {"key": "10.1002/9780470571224.pse540-BIB0059|pse540-cit-0059", "doi-asserted-by": "crossref", "first-page": "452", "DOI": "10.1208/s12248-014-9576-9", "article-title": "A priori prediction of tumor payload concentrations: preclinical case study with an auristatin-based anti-5T4 antibody-drug conjugate", "volume": "16", "author": "Shah", "year": "2014", "journal-title": "AAPS J"}], "container-title": ["Pharmaceutical Sciences Encyclopedia"], "link": [{"URL": "http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F9780470571224.pse540", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 24]], "date-time": "2017-06-24T02:44:52Z", "timestamp": 1498272292000}, "score": 27.680794, "issued": {"date-parts": [[2015, 12, 30]]}, "ISBN": ["9780470571224"], "references-count": 59, "URL": "http://dx.doi.org/10.1002/9780470571224.pse540", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T03:17:25Z", "timestamp": 1574219845088}, "reference-count": 38, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2006, 6, 1]], "date-time": "2006-06-01T00:00:00Z", "timestamp": 1149120000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drug Discovery Today: Technologies"], "published-print": {"date-parts": [[2006, 6]]}, "DOI": "10.1016/j.ddtec.2006.06.011", "type": "journal-article", "created": {"date-parts": [[2006, 7, 11]], "date-time": "2006-07-11T14:02:05Z", "timestamp": 1152626525000}, "page": "145-151", "source": "Crossref", "is-referenced-by-count": 11, "title": ["Prediction and classification of protein functions"], "prefix": "10.1016", "volume": "3", "author": [{"given": "Andreas", "family": "Ruepp", "sequence": "first", "affiliation": []}, {"given": "H. Werner", "family": "Mewes", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Drug Discovery Today: Technologies"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1740674906000357?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1740674906000357?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 19]], "date-time": "2019-04-19T23:52:14Z", "timestamp": 1555717934000}, "score": 27.61628, "issued": {"date-parts": [[2006, 6]]}, "references-count": 38, "journal-issue": {"published-print": {"date-parts": [[2006, 6]]}, "issue": "2"}, "alternative-id": ["S1740674906000357"], "URL": "http://dx.doi.org/10.1016/j.ddtec.2006.06.011", "ISSN": ["1740-6749"], "issn-type": [{"value": "1740-6749", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T02:02:14Z", "timestamp": 1575424934418}, "reference-count": 39, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2014, 3, 1]], "date-time": "2014-03-01T00:00:00Z", "timestamp": 1393632000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drug Discovery Today: Technologies"], "published-print": {"date-parts": [[2014, 3]]}, "DOI": "10.1016/j.ddtec.2013.12.004", "type": "journal-article", "created": {"date-parts": [[2014, 1, 10]], "date-time": "2014-01-10T14:45:59Z", "timestamp": 1389365159000}, "page": "27-32", "source": "Crossref", "is-referenced-by-count": 14, "title": ["Resistance to Raf inhibition in cancer"], "prefix": "10.1016", "volume": "11", "author": [{"given": "H. Eirik", "family": "Haarberg", "sequence": "first", "affiliation": []}, {"given": "Keiran S.M.", "family": "Smalley", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Drug Discovery Today: Technologies"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1740674913000590?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1740674913000590?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 10, 7]], "date-time": "2018-10-07T11:53:02Z", "timestamp": 1538913182000}, "score": 27.28178, "issued": {"date-parts": [[2014, 3]]}, "references-count": 39, "alternative-id": ["S1740674913000590"], "URL": "http://dx.doi.org/10.1016/j.ddtec.2013.12.004", "ISSN": ["1740-6749"], "issn-type": [{"value": "1740-6749", "type": "print"}], "subject": ["Biotechnology", "Molecular Medicine", "Drug Discovery"]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T20:02:47Z", "timestamp": 1574452967558}, "reference-count": 36, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2010, 3, 1]], "date-time": "2010-03-01T00:00:00Z", "timestamp": 1267401600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drug Discovery Today: Technologies"], "published-print": {"date-parts": [[2010, 3]]}, "DOI": "10.1016/j.ddtec.2010.06.005", "type": "journal-article", "created": {"date-parts": [[2010, 8, 4]], "date-time": "2010-08-04T09:27:02Z", "timestamp": 1280914022000}, "page": "e37-e42", "source": "Crossref", "is-referenced-by-count": 11, "title": ["Seeking ligand bias: assessing GPCR coupling to \u03b2-arrestins for drug discovery"], "prefix": "10.1016", "volume": "7", "author": [{"given": "Laura M.", "family": "Bohn", "sequence": "first", "affiliation": []}, {"given": "Patricia H.", "family": "McDonald", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Drug Discovery Today: Technologies"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S174067491000020X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S174067491000020X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 9]], "date-time": "2018-12-09T01:54:49Z", "timestamp": 1544320489000}, "score": 27.239656, "issued": {"date-parts": [[2010, 3]]}, "references-count": 36, "journal-issue": {"published-print": {"date-parts": [[2010, 3]]}, "issue": "1"}, "alternative-id": ["S174067491000020X"], "URL": "http://dx.doi.org/10.1016/j.ddtec.2010.06.005", "ISSN": ["1740-6749"], "issn-type": [{"value": "1740-6749", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T05:37:11Z", "timestamp": 1575178631357}, "reference-count": 24, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2005, 9, 1]], "date-time": "2005-09-01T00:00:00Z", "timestamp": 1125532800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drug Discovery Today: Technologies"], "published-print": {"date-parts": [[2005, 9]]}, "DOI": "10.1016/j.ddtec.2005.08.008", "type": "journal-article", "created": {"date-parts": [[2005, 10, 3]], "date-time": "2005-10-03T13:40:34Z", "timestamp": 1128346834000}, "page": "205-209", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Human aspects of the management of drug discovery knowledge"], "prefix": "10.1016", "volume": "2", "author": [{"given": "Thomas H.", "family": "Davenport", "sequence": "first", "affiliation": []}, {"given": "Manuel C.", "family": "Peitsch", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Drug Discovery Today: Technologies"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1740674905000569?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1740674905000569?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 22]], "date-time": "2019-01-22T01:26:14Z", "timestamp": 1548120374000}, "score": 27.239656, "issued": {"date-parts": [[2005, 9]]}, "references-count": 24, "journal-issue": {"published-print": {"date-parts": [[2005, 9]]}, "issue": "3"}, "alternative-id": ["S1740674905000569"], "URL": "http://dx.doi.org/10.1016/j.ddtec.2005.08.008", "ISSN": ["1740-6749"], "issn-type": [{"value": "1740-6749", "type": "print"}], "subject": ["Biotechnology", "Molecular Medicine", "Drug Discovery"]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T06:14:25Z", "timestamp": 1575180865288}, "reference-count": 0, "publisher": "Wiley", "issue": "5", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 933, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["ChemMedChem"], "published-print": {"date-parts": [[2013, 5]]}, "DOI": "10.1002/cmdc.201300038", "type": "journal-article", "created": {"date-parts": [[2013, 2, 10]], "date-time": "2013-02-10T23:53:28Z", "timestamp": 1360540408000}, "page": "858-858", "source": "Crossref", "is-referenced-by-count": 0, "title": ["ADME-Enabling Technologies in Drug Design and Development. Edited by Donglu Zhang and Sekhar Surapaneni"], "prefix": "10.1002", "volume": "8", "author": [{"given": "Jos H.", "family": "Beijnen", "sequence": "first", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2013, 2, 10]]}, "container-title": ["ChemMedChem"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcmdc.201300038", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/cmdc.201300038", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 5]], "date-time": "2018-08-05T16:34:21Z", "timestamp": 1533486861000}, "score": 26.855034, "issued": {"date-parts": [[2013, 2, 10]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2013, 5]]}, "issue": "5"}, "URL": "http://dx.doi.org/10.1002/cmdc.201300038", "ISSN": ["1860-7179"], "issn-type": [{"value": "1860-7179", "type": "print"}], "subject": ["General Pharmacology, Toxicology and Pharmaceutics", "Organic Chemistry", "Molecular Medicine"]}, {"indexed": {"date-parts": [[2019, 12, 20]], "date-time": "2019-12-20T02:42:57Z", "timestamp": 1576809777908}, "publisher-location": "Third edition / [edited by] Paul G. Pearson, Larry C. Wienkers.", "edition-number": "3", "reference-count": 1, "publisher": "CRC Press", "isbn-type": [{"value": "9780429190315", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2019, 5, 20]]}, "DOI": "10.1201/9780429190315-25", "type": "book-chapter", "created": {"date-parts": [[2019, 6, 6]], "date-time": "2019-06-06T14:38:11Z", "timestamp": 1559831891000}, "page": "667-678", "source": "Crossref", "is-referenced-by-count": 0, "title": ["ADME of Antibody Drug Conjugates"], "prefix": "10.1201", "author": [{"given": "Jiajie", "family": "Yu", "sequence": "first", "affiliation": []}, {"given": "Cinthia", "family": "Pastuskovas", "sequence": "additional", "affiliation": []}, {"given": "Brooke M.", "family": "Rock", "sequence": "additional", "affiliation": []}], "member": "301", "reference": [{"key": "ref25", "unstructured": "Senter, P.D. and E.L. Sievers , The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma. Nat Biotechnol, 2012. 30(7): 631\u2013637.", "DOI": "10.1038/nbt.2289", "doi-asserted-by": "crossref"}], "container-title": ["Handbook of Drug Metabolism"], "deposited": {"date-parts": [[2019, 11, 28]], "date-time": "2019-11-28T11:02:33Z", "timestamp": 1574938953000}, "score": 26.003698, "issued": {"date-parts": [[2019, 5, 20]]}, "ISBN": ["9780429190315"], "references-count": 1, "URL": "http://dx.doi.org/10.1201/9780429190315-25", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T19:49:49Z", "timestamp": 1574711389762}, "reference-count": 47, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2015, 8, 1]], "date-time": "2015-08-01T00:00:00Z", "timestamp": 1438387200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Drug Discovery Today: Technologies"], "published-print": {"date-parts": [[2015, 8]]}, "DOI": "10.1016/j.ddtec.2015.06.004", "type": "journal-article", "created": {"date-parts": [[2015, 7, 16]], "date-time": "2015-07-16T05:32:11Z", "timestamp": 1437024731000}, "page": "1-8", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 19, "title": ["Towards integrative systems pharmacology models in oncology drug development"], "prefix": "10.1016", "volume": "15", "author": [{"given": "J.G. Coen", "family": "van Hasselt", "sequence": "first", "affiliation": []}, {"given": "Piet H.", "family": "van der Graaf", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Drug Discovery Today: Technologies"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1740674915000232?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1740674915000232?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 20]], "date-time": "2018-09-20T22:56:50Z", "timestamp": 1537484210000}, "score": 25.473518, "issued": {"date-parts": [[2015, 8]]}, "references-count": 47, "alternative-id": ["S1740674915000232"], "URL": "http://dx.doi.org/10.1016/j.ddtec.2015.06.004", "ISSN": ["1740-6749"], "issn-type": [{"value": "1740-6749", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Towards integrative systems pharmacology models in oncology drug development", "name": "articletitle", "label": "Article Title"}, {"value": "Drug Discovery Today: Technologies", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.ddtec.2015.06.004", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T05:02:27Z", "timestamp": 1574485347293}, "reference-count": 68, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2010, 12, 1]], "date-time": "2010-12-01T00:00:00Z", "timestamp": 1291161600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drug Discovery Today: Technologies"], "published-print": {"date-parts": [[2010, 12]]}, "DOI": "10.1016/j.ddtec.2010.12.002", "type": "journal-article", "created": {"date-parts": [[2010, 12, 19]], "date-time": "2010-12-19T09:06:15Z", "timestamp": 1292749575000}, "page": "e255-e262", "source": "Crossref", "is-referenced-by-count": 4, "title": ["History of 3D pharmacophore searching: commercial, academic and open-source tools"], "prefix": "10.1016", "volume": "7", "author": [{"given": "John H.", "family": "Van Drie", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Drug Discovery Today: Technologies"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1740674910000545?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1740674910000545?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 7]], "date-time": "2019-06-07T05:49:26Z", "timestamp": 1559886566000}, "score": 25.396425, "issued": {"date-parts": [[2010, 12]]}, "references-count": 68, "journal-issue": {"published-print": {"date-parts": [[2010, 12]]}, "issue": "4"}, "alternative-id": ["S1740674910000545"], "URL": "http://dx.doi.org/10.1016/j.ddtec.2010.12.002", "ISSN": ["1740-6749"], "issn-type": [{"value": "1740-6749", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}